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ABSTRACT

Expression Systems for Synthetic Spider Silk Protein Production
by
Michaela R. Hugie, Doctor of Philosophy
Utah State University, 2019

Major Professor: Dr. Randolph V. Lewis
Department: Biological Engineering
Spider silk is a biodegradable and biocompatible material that is stronger than
steel and more elastic than nylon. These properties make spider silk a desirable material
for many commercial avenues, ranging from textiles to biomedical materials. Due to
spiders’ cannibalistic and territorial nature it is not feasible to farm them to procure spider
silk in large quantities. Therefore, a bioengineered synthetic process is necessary to
produce spider silk. To date synthetic spider silk has been produced in E. coli, goats,
yeast, plants, mammalian cells and silkworms, but none of these processes has provided a
commercially available product. More specifically, limiting factors include: 1) low
purification yields and 2) recombinant spider silk proteins (rSSps) that are much smaller
than the natural proteins and create synthetic fibers with mechanical properties inferior to
those of natural fibers. The size of the protein is directly correlated to the mechanical
characteristics of the resulting fiber.
This research aimed to address the optimization of spider silk production in
varying hosts to attain a commercially viable process, while improving the synthetic
spider silk’s mechanical characteristics through both genetic engineering and expression
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techniques. More specifically, efforts were made to increase the yield and improve the
mechanical characteristics of the rSSps produced in Escherichia coli, Medicago sativa
(alfalfa) and Spodoptera frugiperdes (insect cells). Each host was used to address
different needs pertaining to spider silk research: E. coli provides a quick production
method to produce a large amount of synthetic protein in a relatively short time frame, M.
sativa may provide a high yield production system that can be used in long-term
commercialization, and S. frugiperdes enables post-transcriptional modifications,
specifically glycosylation, that are necessary to create a synthetic aggregate spider silk
with properties that properly mimics the native silk.
In summary, the overall objective of this research was to utilize and improve
several synthetic production systems. Improvements were aimed towards a
commercialization process for rSSps with mechanical features comparable to native silks.
While both yields and properties were improved, further research is necessary to create a
commercially viable process and product.
(123 Pages)
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PUBLIC ABSTRACT

Expression Systems for Synthetic Spider Silk Protein Production
Michaela R. Hugie
Spider silk is a biodegradable and biocompatible natural material that is stronger
than steel and more elastic than nylon. These properties make spider silk a desirable
material for many commercial products, ranging from textiles to biomedical materials.
Due to spiders’ cannibalistic and territorial nature it is impossible to farm them to
produce spider silk at a high enough yield to meet product demands. Therefore, a
bioengineered synthetic process is necessary to produce spider silk. Synthetic spider silk
has been produced in bacteria, goats, yeast, plants, mammalian cells and silkworms, but
none of these processes provided a commercially viable yield or were able to express
recombinant spider silk proteins (rSSps) that can mechanically imitate the natural spider
silks. The overall goal of this research was to increase the yield and mechanical
characteristics, e.g. strength and elasticity, to create a commercially viable spider silk.
Three different hosts were used: E. coli, alfalfa and an insect cell line. Each host
addresses issues with synthetic protein production in both the short-term and long-term
scheme. Through this research yields were increased, while the mechanical properties of
the synthetic silks were improved and groundwork for future research into the
improvement of synthetic spider silk production were identified.
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CHAPTER 1
INTRODUCTION
Spider Silk
Since spider silk’s remarkable mechanical and biological characteristics were first
observed, humans have been attempting to utilize it in varying applications. Spider silk
has been shown to be a material that contains not only considerable strength, but is also
highly extensible 1–3. Spider silk has been proven to be stronger than steel4–6 and as
elastic as rubber7,8, but spider silk’s mechanical characteristics are not the only novel
features it possesses. Even though the term biocompatible was not coined until the
1970s9, the characteristic was observed in spider silk thousands of years ago, leading to
people harvesting entire orb webs and using them to dress wounds. Spider silk’s
biocompatibility10–13 and biodegradability2 characteristics make it an ideal material for
many medical materials including: sutures14,15, tendon/ligament replacements16,17, drug
delivery devices18–20, and coatings for catheters21 to name a few and much like silkworm
silk, spider silk has been utilized as a textile on occasions since the 1700’s22.
Over the last 450 million years, spiders have evolved specialized silks for a
variety of purposes23,24. Research has focused on orb weaving spiders, specifically
Nephila clavipes of the Araneidae family, rather than non-orb weaving spiders, who lack
fiber versitility4. N. clavipes has six different types of silk and one glue: aciniform, major
ampullate, minor ampullate, piriform, tubiliform, flagelliform and aggregate5 (Figure 11). Each of these silk proteins mechanical properties varies according to their function
within the orb web and may have more than one protein forming them5,25–27. Major
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ampullate silk, more commonly known as dragline silk, has a tensile strength that is
comparable to Kevlar ©4,5,28, while flagelliform silk has a strain higher than a human
ligament combined with a toughness greater than rubber and the ability to elongate to
more than 200% its original size while being able to recover back to its original length7,8
(Table 1.1). While we know that native spider silk’s mechanical properties are due to
their genetic sequences, past research has shown that synthetic silks’ mechanical features
can be tuned by both genetic sequence alteration and post-spin manipulation of the
synthetic protein materials. While a synthetic spider silk fiber has been created that has
comparable mechanical properties to that of native spider silk, to date a process that can
reliably produce the fibers in large, commercially viable quantities has not been
established29.
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Fig. Error! No text of specified style in document.1-1 Diagram representing
Araneidae spider silk types, glands and function30
Table 1-1 Mechanical property table comparing spider silk and other materials
Material

Strength
(MPa)
4000
1000

Strain (%)

Dragline silk
35
Minor
5
ampullate
silk
Flagelliform
1000
>200
Tubiliform
1000
20
silk
Bombyx
600
20
mori silk
Kevlar 49
3600
5
Rubber
50
850
Tendon
150
5
Ligament
20
150
Bone
160
3
aData from ref. (Gosline), (Lewis), (Kaplan)

Toughness
(KJ/kg)
400
30

400
100
60
30
80
5
1.6
3
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In order to understand spider silks’ extraordinary mechanical properties,
researchers’ focus turned to the chemistry and secondary structure of the proteins.
Through amino acid analyses (AAA), protein sequencing and gene cloning the primary
structure was determined for various orb weaving spiders’ silk proteins. Dragline silk was
among the first silks examined and was shown to have a high glycine and alanine content,
accounting for greater than 50% of the amino acid composition31. Glycine and alanine
were not the only amino acids that were found in great abundance within dragline silk;
over 90% of the silks’ amino acid composition is accounted for by only six amino acids:
glycine, alanine, serine, glutamine, proline and arginine. Upon further investigation into
the other spider silk proteins it was discovered that a high glycine and alanine content
was common among all the proteins, although with some variation. Some differences
among the silk proteins include: 1) the absence of proline in minor ampullate silk32, 2) a
low alanine concentration in aciniform33, 3) proline in abundance in piriform34 and 4) a
high serine content in tubuliform35,36. These variations in amino acid composition found
in the different silk types were believed to contribute to the differences in mechanical
properties present. Through X-ray diffraction, amino acid analyses, nuclear magnetic
resonance (NMR), circular dichroism and Raman spectroscopy the primary structure for
spider silk was assigned to specific secondary structures that attributed elasticity and
strength to the fibers 37–45.
Within the spider silk protein’s sequence there are three notable structural motifs
(Figure 1.2). These motifs govern the elasticity (GPGXX/GPGGX) and strength
[(GA)n/(A)n and GGX] characteristics exhibited by the fibers46. The fibers’ motif
concentration quantitatively determines its mechanical properties, making synthetic
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spider silks tunable at the genetic level. If the poly-alanine motif is reiterated at a higher
concentration in a particular silk, than the correlating mechanical property, in this case
strength, will be higher, and so forth. Due to high repetitions of these motifs in silks it
follows that the larger, in kDa, the protein is, the better or higher the mechanical
properties. Specifically, the more the strength motifs are repeated the greater the strength,
and the same for the elastic motifs8,33.
Once the primary structure was elucidated, researchers could determine the
secondary structure that helped drive the protein’s function. The GPGXX/GPGGX motif
forms a β-spiral secondary structure, due to the prolines. The β-spiral acts like a slinky,
allowing the fiber to stretch and retract without permanent deformation, leading to a high
elasticity in proteins containing these motifs 40,41,47,48. GGX repeats create Gly II helices,
creating a rigid structure within the fiber. As the strength characteristics observed in
spider silk have been assigned to the (GA)n/An motifs, it is not surprising that X-ray
diffraction43,45,49,49, NMR40,41,48, Raman spectroscopy42,50, and Fourier transform infrared
spectroscopy (FTIR)51 studies show that these motifs lead to a secondary structures that
forms stiff crystalline β-sheets. These crystalline β-sheet regions act as the zipper,
backbone in the proteins and when they are aligned upon spinning, cause the fiber to have
an increased tensile strength (Figure 1.2).
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Fig. Error! No text of specified style in document.2-2 A representation of the
mechanical properties for each spider silk type and the motifs that drive secondary
structure within the silk’s sequences 14
As would be expected there are some additional differences found in aggregate
spider silk, which is the adhesive protein that the spider secretes and uses to capture
prey52,53. The aggregate protein is excreted as droplets onto the web. One main difference
in aggregate silk versus other silks is that it is a glycoprotein and while it is known that
aggregate is glycosylated post-translationally, researchers has proven that the
glycosylation is both O- and N-linked54–5725,53,58–61. Other than the glycosylation found in
the aggregate, the gene follows many of the same genetic patterns as the other silks, such
as a conserved C-terminal and glycine/proline rich repetitive motifs25,58.
Synthetic Production and Current Limitations
Due to orb weaving spiders’ cannibalistic and territorial nature, it is impossible to
successfully farm them to procure spider silk commercially. Therefore, a bioengineered
synthetic process is necessary to efficiently produce spider silk. To date synthetic spider
silk has been produced in E. coli5,62–66, goats (Nexia Biotechnology, unpublished),
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yeast67, plants68,69, mammalian cells70 and silkworms64,71,72, but none of these processes
provided commercially viable yields or are able to express recombinant spider silk
proteins (rSSps) that can mimic the sizable natural silks63,67,71,73–75 (Figure 1-3).
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Fig. 1-3 Brief history of recombinant spider silk protein production (a) Production
of synthetic spider dragline silk protein in Pichia pastoris in 199613, (b) synthetic spider
dragline silk proteins and their production in Escherichia coli in 199717, (c) production of
spider silk protein in tobacco and potato in 200112, (d) spider silk fibers spun from
soluble recombinant silk produced in mammalian cells in 200218, (e) expression of
EGFP-spider dragline silk fusion protein in BmN cells and larvae of silkworm, which
showed that solubility is the primary limitation for the yield of spider silk protein, in
200719, (f) construct synthetic gene encoding artificial spider dragline silk protein and its
expression in the milk of transgenic mice in 200720, (g) transgenic silkworms (B. mori)
producing recombinant spider dragline silk in cocoons in 200921, (h) engineering
the Salmonella type III secretion system to export spider silk monomers in
200922, (i) native-sized recombinant spider silk protein produced for the first time in
metabolically engineered E. coli resulting in a Kevlar-strength fiber in 201023,
and (j) transgenic silkworms transformed with chimeric silkworm–spider silk genes
producing composite silk fibers with improved mechanical properties in 201224. The
organization of the important motifs in spider silk proteins, which is modified from
Hayashi et al.25 and Teule et al.14. The colored-squares indicate the modules contained in
each silk protein. The proteins are: MaSp1 and MaSp2, major ampullate spidroin 1 and 2
from Nephila clavipes; ADF-1, ADF-2, and ADF-3, minor ampullate, putative
cylindrical, and major ampullate, respectively, from Araneus diadematus25 (Reprinted
from Chung et al.7 with permission) 76
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The redundant motifs in spider silk lead to a protein composition of up to 80%
glycine, proline, and alanine77. Spider silk protein’s large molecular weight and repetitive
nature cause some primary difficulties in synthetic production. Literature indicates that
the limitations in synthetic production can be explained by analyzing the silks’ genetic
sequences and the innate biochemistry of the hosts62,78. The native spider silk proteins are
large, ranging from 200-350 kDa. Due to the spider silk genes highly repetitive nature
and large size, there has been limited success in expressing a native-sized recombinant
silk protein in any host. Glycine, proline and alanine in particular are vital to producing a
full-length spider silk protein. The two limiting factors in spider silk production are: 1)
there is no commercially viable process that produces native-sized proteins and 2)
synthetic fibers have been unable to match the mechanical properties of natural fibers
(Table 1-2).
Table 1-2 Synthetic spider silk yields, sizes and goals in different production hosts
versus the orb-weaving spider Nephila clavipes
Source
N. clavipes
Goats
E. coli
Silkworms
Alfalfa

Spider Silk Size
(kDa)
250-500
127
127
240
80-120

Yield
NA
0.5-2 g/L
0.7 g/L
10-20%
unknown

Goals
NA
2-5 g/L
1 g/L
50% spider silk
1% yield

Not only are the characteristics found in different spider silks widely variable and
promising, but so are the diverse materials that can be made from their protein
components. This is mostly due to the plethora of ways that spider silk can be processed,
turning spider silk into more than just a fiber. Once the synthetic proteins have been
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produced into a dried protein after purification and lyophilization there are many ways of
processing. It can be spun into a fiber5,79–81 or resolubilized with heat and pressure to
make a dope that under different conditions can create hydrogels19,82–88, sponges, films,
and aerogels89 (Figure 1-4). In order to make all of these novel materials, a large amount
of spider silk protein will need to be made to make product development viable.

Fig. 1-4 Schematic showing some potential materials that can be made using
synthetic spider silk 90

E. coli (Bacteria)
Escherichia coli is of particular interest as a host for spider silk production due to
its relatively fast production time, cost and it is commonly used as a host in industry and
therefore has been well studied as a host for synthetic production. One issue in producing
spider silk proteins in E. coli is that the bacteria does not naturally produce proteins that
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are in the same molecular weight range or proteins that require such high amounts
glycine, and innately have a smaller concentration tRNA pool available to them than that
which is found in spiders5,63,66,91,92. During translation, a deficiency in either amino acid
availability or the correct tRNAs can cause the ribosome to “fall off”. If the ribosome
falls off prior to reaching the stop codon, premature translational termination occurs and a
truncated protein is the result.
Many different methods have been employed to improve spider silk protein
production in E. coli, including: the addition of supplementary amino acids, specifically
glycine, alanine and proline to the media, to make them more available to the bacteria for
translation, this ultimately failed to improve expression and protein size67. To alleviate
these problems one study showed that the addition of glycine tRNAs in E. coli leads to
successful production of larger proteins with consequently, better mechanical
characteristics (Figure1-5). These results were not reproduced until recently, and
originally were only conducted for major spidroin 1 (MaSp1) protein with no additional
proline tRNAs, which are necessary for major spidroin 2 (MaSp2) protein production62.
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Fig. 1-5 Diagram showing the research results from a study conducted in 2010 by
Xia et. al. Where synthetic silk constructs ranging in size from 16 motif repeats (16mer)
to 96 motif repeats (96mer). C) shows the Young’s modulus plot for each construct, D)
shows tenacity (MPa), E) shows the percent breaking strain, or elasticity, in each
construct, and F) shows a calculation of the Young’s modulus plot for each
construct62,93,94

Medicago sativa (Alfalfa)
Medicago sativa, alfalfa, is another host that has the capability to produce spider
silk at a yield that is commercially viable and more economic than some other production
hosts68. Alfalfa is a perennial crop that can be harvested up to four or more times a year
and has been utilized as a genetic engineering host since the 1980s with great success in
both protein production and yield. The USDA has approved alfalfa as an appropriate
genetic host for protein and peptide production for years and companies, such as
Medicago ® and Forage Genetics ®, currently grow transgenic fields with commercial
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product95–99. Total protein content in alfalfa is 24% dry weight, and past research has
shown yields of up to 5% dry weight synthetic protein. A 2% dry weight spider silk yield
in alfalfa would produce 218 kg spider silk per acre per year, a yield that supports
commercialization.
The main setback encountered in spider silk production in alfalfa comes when the
spider silk protein is extracted from the harvested material. In all the hosts a polyhistidine tag is employed at the C- or N- termini, more commonly the N-terminal, as a
means to extract the desired rSSps via HPLC with a column charged with nickel (Ni2+),
also known as Nickel immobilized metal affinity chromatography (IMAC). When the cell
lysate is sent over the column the charged poly-his6 tag should bind to the oppositely
charged nickel, which acts as a ligand, and the rest of the lysate should flow through into
the waste, then using imidazole the protein can be eluted from the column and collected
to be processed into a final pure product. In the alfalfa’s case there is the complication of
chlorophyll, which can also bind to the metal ion and is difficult to remove due to the
molecule’s phytol tail. In order to successfully produce spider silk in alfalfa, creating a
commercially viable process, this problem must be resolved.
Bombyx mori (Silkworms)
Bombyx mori¸ silkworms, have also been employed as a host for synthetic spider
silk production. While synthetic production in silkworms is advantageous in that the
rSSps are spun into fibers, there are several negative aspects to this production system.
Research using CRISPR/Cas9 initiatied non-homologous end joining, native-size spider
silk genes have been integrated at defined locations in the fibroin genes of the silkworm.
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The mechanical properties of these transgenic spider/silkworm fibers are similar to those
found in the native silks100. This 15% integration greatly increases the mechanical
properties, so that they approach that of native spider silks. (manuscript submitted and
under review as of the time of this writing)
Some issues that are innate to production via silkworms is that while it is
convenient that the silkworm spins the spider silk proteins as a chimera with silkworm
silk71,72,101, it is nearly impossible to deconstruct the fibers to make any other material,
such as sponges, hydrogels etc. Another issue with production in silkworms is that their
silk is coated with a protein called sericin that is not biocompatible, rending any material
made with these synthetic fibers useless in medical applications unless a degumming
process is employed. The degumming process itself does not always have a 100%
efficiency and upon degumming research has shown a decrease in mechanical
characteristics of the fibers102.
Goats
Utilizing goats as a synthetic spider silk host is an attractive option due to the fact
that the targeted protein can be expressed in tandem with the goat’s milk proteins and
produced in the milk. Goats are relatively small, in comparison to other milk producing
farm animals, they produce high protein content milk at a comparatively high volume,
and it is only a two-year waiting time from birth to reproduction, and therefore milkproducing, age. In 2002 Nexia Biotechnologies, along with Randy Lewis’ laboratory,
created transgenic goats containing the spider silk gene, creating transgenic goats capable
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of producing spider silk in their milk (Nexia Biotechnologies, unpublished). The spider
silk genes are heritable and can be passed on to progeny.
Currently this is the highest producing system for synthetic spider silk, although
the spider silk protein being expressed is only a 65 kDa protein and they are only
producing the major ampullate silk proteins. The high production rate in these transgenic
goats has allowed to for improvements to the fiber spinning process79, creating fibers that
more closely mimic the native spider silk, and other methods for material development to
be discovered: including hydrogels, aerogels, sponges and films89,90. Despite the current
success using goats as a host for spider silk production, upscaling the goat herds is a
concern due to high costs for non-therapeutic protein, especially for markets that require
a large amount of material.
Eukaryotic Cell Culture (SF9 and BmN)
One potential method to synthetically produce spider silk is through cell culture in
various eukaryotic cells, namely Spodoptera frugiperdes (SF9/SF21) and Bombyx mori
(BmN) cells, which have already produced spider silk-like proteins. Although only a 70
kDa synthetic silk has been produced with a very low yield of 5% total cell protein in
BmN cells, resulting synthetic spider silk proteins produced in SF9 cells have proved
very weak or fragile, making it difficult to form tangible products with them or
mechanically70. There are concerns that, like with E. coli, the eukaryotic cell lines will
have difficulties producing spider silk proteins that are as large as native proteins, not just
due to the size of the proteins, but also the repetitive nature contained in the genetic
sequence for the proteins which can cause a depletion in the aminoacyl-tRNA pool
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creating truncated proteins. Cell cultures costs is also a concern, with the cost being
expensive in comparison to other production processes. While research in our laboratory
has shown that spider silk gland cells may produce spider silk proteins in culture, a
glandular cell line has remained unattainable due to difficulties with proliferation
(unpublished).
Modern research into spider silk has only heightened the materials status as a
super biomaterial and given insight into the applications able to be engineered using these
novel proteins. Now that the genetic code has been unraveled, it has revealed that the
mechanical properties can be manipulated to fit a wide variety of applications and it has
become necessary to continue research into developing synthetic spider silk at a rate that
can meet the pressing demands to create spider silk biomaterials. With newly developed
materials making headway and prototypes in demand, this necessity is only intensified.
Once processes to create synthetic spider silk that are capable of meeting these demands
are produced, centuries of human perseverance and curiosity will have paid off. It is a far
step from those in the past that would collect full spider webs with sticks to use as wound
dressings or those in the more recent past that would sit for hours forcibly silking spiders
to obtain enough to make small textiles. There will now be a facile process to create
multiple materials to fit varying needs, all from synthetic spider silk.
Research Aims
The overall goal this research aims to achieve is optimizing spider silk
production in a variety of hosts to attain a commercially viable process, while
improving the synthetic spider silk’s mechanical characteristics through both
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genetic engineering and expression techniques. There are three different projects that
are discussed below for expressing and purifying spider silk in varying hosts. The
resulting expressed protein will be used for other material-oriented projects throughout
the laboratory and the mechanical data acquired will be integrated to further research into
improving both production and product characteristics.
Objective #1: E. coli
The first objective was to increase the expression capability in E. coli, both by
increasing expression yields and the molecular weight of the synthetic spider silk protein
produced. By applying molecular cloning methods glycine, alanine and proline tRNAs
were inserted into an expression vector, therefore being expressed in tandem with
selected spider silk genes. The poly-histidine tag placement was also experimented with,
to see if a C-terminal or a N-terminal tag would improve expression and/or full-length
protein purification.
Objective #2: Alfalfa
A second objective was to produce recombinant spider silk proteins (rSSps) in
Medicago sativa, alfalfa. Using molecular cloning and bioengineering methods an agrotransformation vector was created ensuring selected proteins would be retained in the
endoplasmic reticulum, resulting in synthetic protein expression being contained within
the plant’s leaves and increasing the proteins expression. A new purification method was
necessary due to the interaction from the chlorophyll molecule and the resin used for
HPLC.
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Objective #3: Spodoptera frugiperdes
The third, and final, objective of this research was producing a synthetic
aggregate spider silk protein in Spodoptera frugiperda, the SF9 cells. Since aggregate is
an adhesive protein and, like most biological protein-based glues, is glycosylated it must
be expressed in a host that has the ability to post-translationally modify the synthetic
protein with glycans. While E. coli does not post-translationally modify proteins to have
N- or O- glycosylation both Medicago sativa and Spodoptera frugiperda do. Due to the
rapid genetic integration and expression of selected synthetic proteins into SF9 cells
versus the agro-transformation method used to insert and express synthetic proteins in
alfalfa it was decided to express aggregate in SF9 cells for initial research. Two other
reasons that SF9 cells are attractive is due to their reduced generation times and potential
easy rSSp purification.
In summary, the projects listed are an effort to address production issues, namely
creating a yield capable of supporting commercialization and increasing the rSSps
molecular weight, and in a proportionate way the mechanical characteristics, to more
closely mimic the native spider silk genes. By addressing these issues in multiple hosts
both a short-term and a long-term approach to production can be established. The
resulting rSSps will support product research and eventually commercialization.
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CHAPTER 2
IMPROVING SYNTHETIC SPIDER SILK PROTEIN PRODUCTION IN
ESCHERICHIA COLI UTILIZING VECTOR ADAPTATIONS

Chapter Preface
This chapter describes the research conducted into improving recombinant
synthetic spider silk protein (rSSp) production in Escherichia coli through molecular
cloning with the expression vector pET19b. In order to address production issues,
molecular engineering was utilized creating four different vectors: 1) pET19-SX, a
pET19b-derived vector containing additional glycine and proline tRNAs and a serine
hydroxyl methyl transferase (SHMT) enzyme that turns serine into glycine, 2) pET19SXC, which is identical to the pET19-SX vector with the poly-histidine tag being moved
from the N-terminal to the C-terminal, 3) pET19K, a kanamycin resistant version of the
commercially available ampicillin resistant pET19b and 4) pET19KC, this vector is the
same as the commercially available pET19b vector from Invitrogen ® except having
kanamycin resistance, rather than ampicillin, and a C-terminal poly-histidine tag. These
vectors were hypothesized to increase rSSp yields and mechanical characteristics and
also allow for larger proteins to be produced. Strength and elasticity would increase based
on the increased capability of E. coli to produce larger rSSps, that are more similar in size
to native spider silk proteins.
The Invitrogen ® commercially available vector pET19b was used as a base
vector for comparison in expression, as well as the vector genetically modified with
inserts creating the pET19SX, pET19SXC, pET19k and pET19KC vectors. The
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modifications applied to the above vectors resulted in very large vectors, which has often
led to difficulty in expression and fermentation of E. coli. Shortly after these vectors were
constructed a co-expression system was also created, with one vector containing the extra
tRNAs and SHMT sequences, and the second vector containing the target spider silk
gene. This research was not conducted for this specific dissertation, but bears mention.
The research presented in this chapter was conducted in 2012-2014, so it is not current
and further research has been conducted leading to a more successful bacterial production
system for rSSps. Regardless, the research presented in this chapter is presented as it was
a precursor to the current production process and success in E. coli.
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Introduction
One of the most popular systems used for synthetic protein production is the
gram-negative bacterium Escherichia coli, this is due to fermentation being relatively low
cost, in regard to other synthetic protein production processes. E.coli has a fast generation
time that ensures rapid biomass accumulation, and the process is straight forward to scale
up103. These particular characteristics make E. coli one of the first and most common
production systems for spider silk proteins. Since spiders are cannibalistic and territorial
a synthetic production system is needed and E. coli provides a quick and relatively cheap
expression system. To date, synthetic spider silk has been produced in E. coli5,62–66, goats
(Nexia Biotechnology, unpublished), yeast67, plants68,69, mammalian cells70 and
silkworms64,71,72, but due to the comparatively low cost and fast processing time
production in bacteria is attractive in the long-term.
While recombinant spider silk proteins (rSSp) have been produced in E. coli
through fermentation, the resulting yields are not high enough to meet commercial or
research demands, and the synthetic proteins produced did not create fibers of the same
strength as the native spider silks. The inferior mechanical properties innate to the rSSps
were due to the smaller protein size versus the large native spider silks, ~25-65 kDa in
comparison to 250-500 kDa. Additionally, the highly repetitive nature of spider silk
proteins leads to ribosomal fall-off and, therefore, truncated-versions of the protein are
produced66,104,105.
Many researchers attempted to address the low yield and truncation issues by
optimizing the codons in the gene sequences to more closely match that of the
heterologous host106 and by altering the expression vectors to contain kanamycin
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resistance, rather than the less stable ampicillin resistance63,66,106,107. While this led to a
10X increase in production, it did not resolve the issues with truncated protein nor did
these attempts improve yields.
In order to make a commercially viable synthetic spider silk production process
the fermentation costs need to be lowered. While fermentation is generally a low-cost
production process, this was not proving to be the case with spider silk. Factors driving
the high cost were believed to be one or a combination of the following factors: 1)
materials, 2) equipment, 3) labor and 4) yields. By increasing the rSSp yields an inverse
in production costs is achieved, due to there being no effect on the materials, equipment
or labor costs, therefore the most feasible way to lower production costs is by improving
spider silk yields (Figure 2-1). Through computer simulation it was determined that a
rSSp yield of even 2 g/L would meet the economic and material demands for high end
commercialization108.

Fig. 2-1 Data accrued showing spider silk protein yields effect on cost108
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Research was conducted based on the theory that the main limiting factor in
spider silk production in E. coli was the availability, or in this case unavailability, of the
most highly used amino acids found in the gene’s repetitive motifs. Doping the media
with glycine, proline and alanine, the three most common amino acids in most spider
silks9–13, may lead to complete translation of the proteins. However, the resulting rSSps
from these experiments were only marginally larger than those produced without doping
the media, and the yields were not significantly increased. These results led to a second
theory: the limiting factor in spider silk protein production in E.coli was not the amino
acid concentration, but a deficit in the t-RNAs that coded for these amino acids73. If the tRNA pool in E.coli has a lower glycine, proline and alanine concentration, the result
would translational pauses that would lead to ribosomal fall off and truncated
proteins66,73,106,110–112.
The main focus of this research was to improve synthetic spider silk yields in E.
coli through genetic manipulation of the expression vector. More specifically, the effect
of adding glycine and proline t-RNAs within the expression vector and the translocation
of the histidine tag used to purify the targeted proteins from the N-term to the C-term on
both protein yields and size. By relocating the purification tag to the end of the sequence
it was theorized that only full-length proteins would be purified from the fermentations.
The additional t-RNAs and a serine hydroxyl methyl transferase (SHMT) had been
shown in past experiments to increase both the size of synthetic protein produced and the
resulting yield62. SHMT is a ubiquitous pyridoxal 5’-phosphate (PLP) dependent enzyme
that catalyzes the reversible interconversion of L-serine and glycine, therefore providing
an enzymatic pathway for the conversion of serine into glycine.
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Four vectors were created based on Invitrogen’s pET19b ®: 1) pET19-SX,
containing additional t-RNAs and an SHMT, 2) pET19-KC, has a C-terminal histidine
tag rather than the generic N-terminal tag, and pET19-SXC, has a C-terminal histidine
tag and the additional t-RNAs and SHMT. A MaSp2 rSSp was inserted into each novel
vector, as well as the original pET19k, and expression was compared for both flask and
bench culture. Comparison was conducted using Western blot analyses and by the
resulting yields from the fermentations of the different constructs. Results from this
research were implemental in the concurrent and present research and production of
rSSps via bacterial fermentation.
Materials and Methods
pET19 Vector Evolution:
For this research four different vectors were created via molecular cloning
methods and utilized to examine the effects of additional t-RNAs, a serine hydroxyl
methyl transferase (SHMT) and relocating the histidine tag used for purification from the
N-term to the C-term would have on rSSp production in E. coli (Figure 2-2). These
additions and alterations were used in tandem, as well as individually to examine what
exactly was improving protein yields and/or limiting protein truncation. The four vectors
are: 1) pET19k, a modified Invitrogen pET19b vector with kanamycin resistance, rather
than ampicillin, 2) pET19-KC, this vector has translocated his-tag from the N-terminal
side of the multiple cloning sites (MCS) to the C-terminal, 3) pET19-SX, which has
additional glycine and alanine t-RNAs, as well as, a SHMT cloned in after the MCS but
prior to the stop codon, and 4) pET19-SXC which is the same as pET19-SX but has a
relocated his-tag on the C-terminal (Table 2-1).
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Fig. 2-2 Vector evolution from Invitrogen’s pET19b® to pET19k to pET19SX

Table 2-1 Vector composition breakdown including: the location of the histidinetag and presence of glycine and proline t-RNAs and a serine hydroxyl methyl
transferase (SHMT)
Vector
pET19k
pET19-KC
pET19-SX
pET19-SXC

Tag loci
N-term
C-term
N-term
C-term

Gly t-RNA
No
No
Yes
Yes

Pro t-RNA
No
No
Yes
Yes

SHMT
No
No
Yes
Yes

Spider Silk Protein Gene Cloning
This research used a 16-Mer, 16 repeats of a major spidroin monomer, MaSp2
(National Biosciences), 1825 bp major ampullate silk spidroin, sequence created by Dr.
Michael Hinman (Figure 2-3). The MaSp2 sequence and vectors were cut with the
restriction enzymes BamHI and NdeI, at the C and N-terminus respectively) and then
ligated using a T4 DNA ligase (New England BioLabs M0202S); the resulting ligations
were electroporated into XL1-Blue Supercompetent Cells (Agilent/Stratagene C2992) at
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1800V. Once clones were screened and the sequences verified, they were transformed
into BL21 competent E. coli (New England BioLabs C2530H) for expression studies.

5’

GATCCC(CCGGGTGGCTATGGTCCTGGACAGCAAGGTCCTGGCCG
GTCCTGGCCAACAGGGTCCCTCTGGTCCAGGCAGTGCAGCTGCCG
CGCAGCGGGT)16CCGGATCAAGCTTATCGATACCGTCGGGATC3’
Fig. 2-3 Nucleotide sequence for a synthetic major ampullate spidroin
(MaSp2). Nucleotides in red represent the repeated monomer, this monomer is
repeated 16X making this sequence a 16-mer.

Expression Assays and Western Blot Analyses
Expression assays were conducted using 5 mL kanamycin (100 mg/m) LB media
(Miller 71753-6) in 15 mL culture tubes and were inoculated with 1 colony forming unit
from a kanamycin (100 mg/mL) agar plate containing the MaSp2 construct: including
pET19k-MaSp2, pET19KC-MaSp2, pET19SX-MaSp2 and pET19SXC-MaSp2. The
culture tubes were grown in a shaking incubator at 37°C until an OD600 of 0.8 was
reached and then expression was stimulated with 1 mM Isopropyl β-D-1thiogalactopyranoside (IPTG) and grown an additional 4 hours. A 1 mL sample was
harvested every hour starting at 0 hours, after inoculation to test for protein expression.
The harvested cells were centrifuged and the pellets were resuspended in 100 µL of 2X
SABU, sonicated for 15 seconds at 0.5-1W, centrifuged and the lysate was collected for
examination.
Western Blots were conducted on all processed cell pellets from the expression
assays to determine MaSp2 production over the course of the culture. A 35 µL aliquot
was taken from each sample and loaded onto a 4-20% tris-glycine SDS-PAGE gel
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(Invitrogen XP04200BOX) and run at 135 V for 90 minutes. Gels were transferred to
nitrocellulose membranes overnight at 25 mA in a wet transfer apparatus. The blots were
conducted on the nitrocellulose membranes with a primary antibody produced in mice
that targets the histidine tag (Rockland 200-303-382, 1:1000 dilution). A rabbit antimouse antibody conjugated with Alkaline Phosphatase (AP) was used at a 1:5000
dilution (Abcam ab6729). The membranes were developed using 1-StepTM NBT/BCIP
Substrate Solution (ThermoFisher Scientific 34042) for imaging.
Bench Fermentations and HPLC
A New Brunswick BioFlo/CelliGen 115 benchtop bioreactor (BF115) was used
for all culture experiments for expression of the MaSp2 in the various vectors.
Fermentations were conducted using fed-batch aerobic fermentation conditions. A cell
culture seed of 100 mL was used to inoculate media containing LB, glucose (25 g/L),
trace metals (1X), magnesium sulfate (.002 M), yeast extract (5 g/L), phosphate (10 g/L),
thiamine (2.5 g/L), kanamycin (100 mg/mL) and 0.3% v/v antifoam A (Sigma-Aldrich
A6582). The fermentation was grown until OD600 of 80 was reached and then inoculated
with 1 mM IPTG and grown for an additional 4 hours. Bacteria was harvested via
centrifugation at 6000 rpms for 30 minutes and the cell pellet was processed in an 8M
Urea binding buffer (8M Urea, 20 mM Tris-HCL, 0.5 M NaCl, 2 mM EDTA) at 1:3.
Sonication was conducted at 1 W for 4 minutes, a minute rest, and repeated 3 times
(QSonica ¾” diameter probe). The cell lysate was harvested through centrifugation at
6000 rpms for 30 minutes, retaining the supernatant as the final cell lysate.
Protein purification was conducted using immobilized metal affinity high
performance liquid chromatography (IMAC-HPLC) utilizing the polyhistidine (6X) tag
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on the MaSp2 constructs, either at the N- or C-terminus depending on the vector. An
AKTA Avant was used with Ni-NTA resin (GE XK-16, bed height 14 cm). Sample was
applied to column at 1 mL/minute and clarified lysate was applied across the column
from both the top and bottom, separately to ensure complete application. The column was
washed with running buffer (0.5 M NaCl, 20 mM Tris-HCL, 0.5 mM EDTA) and wash
fractions were collected. 5 mL elution fractions were collected for 3 column volumes at
5%, 10% and 100% imidazole. Samples of these fractions were mixed 1:1 with 2X
SABU with 6 M Urea and heated for 15 minutes at 100°C. These samples were analyzed
by SDS-PAGE and western blot as described above.

Results and Discussion
Cloning and Expression Assays
The MaSp2 16-mer used as the rSSp to examine the effects additional t-RNAs,
SHMT and relocation of the his-tag to the C-term had on spider silk expression was cut
with the restriction endonucleases BamHI and NdeI then ligated into pET19k, pET19SX,
pET19KC, or pET19SXC cut with the same enzymes. After transformation into XLBlues
E.coli cells, transformants were examined to determine whether the constructs had been
successfully ligated and transformed. Clones were screened by digestion with BamHI and
NdeI, which would yield two bands: the vector used and the other running at 1825 bp for
the MaSp2 16-mer (Figure 2-4). Cloning the MaSp2 into the pET19k, pET19SX,
pET19SXC and pET19KC were successful. The resulting clones were then transformed
into BL21 E. coli enabling protein expression experiments.
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Fig. 2-4 Confirmation of plasmid construction of MaSp2 +pET19SX via gel
electrophoresis. The MaSp2 + pET19SX plasmid was cut with the restriction enzymes
BamHI and NdeI. Two bands are present: 1) the top band is the linearized 6200 bp
pET19SX vector and 2) the lower band is the MaSp2 spider silk insert at 1825 bp.

Expression assays were conducted using MaSp2+pET19k, MaSp2+pET19SX,
MaSp2+pET19SXC and MaSp2+pET19SXC clones with samples taken every hour from
induction, starting at hour 0 to hour 6, to characterize protein expression in a qualitative
fashion over time and to ultimately compare the different vectors expression of the rSSp.
There was some protein expression in the assays before induction, but the 65 kDa MaSp2
was expressed with minimal truncation for 6 hours (Figure 2-5). Western blots showed
protein production over all 6 hours after induction, so it was decided to run the rest of the
experiments under these conditions.
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MaSp2: 65 kDa

Fig. 2-5 Western blot of a 65 kDa MaSp2 in pET19SX expression assay conducted
in BL21 cells. Samples were taken at 0, 4, and 6 hours post-induction from two different
assay cultures.

Western blot analyses of the expression assays conducted on MaSp2+pET19k and
MaSp2+pET19SX showed a significant increase in protein production both over time and
when using the pET19-SX vector (Figure 2-6). Although these were only qualitative
results, they were promising enough to move to benchtop fermentation and full-scale
purification to determine quantitatively how much the yield increased when using the
pET19SX vector. These preliminary results showed that the addition of glycine and
proline tRNAs, as well as the SHMT, increased the yield spider silk protein produced in
E. coli.
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MaSp2: 65 kDa

Fig. 2-6 Western blot showing a protein growth assay comparison between
expression of MaSp2 (65 kDa) in the expression vectors pET19k and pET19SX.
Samples were taken 1-, 2-, 3- and 4-hours post-induction to show protein accumulation
over time.

Western blot analyses on the expression assays of all the constructs
(MaSp2+pET19k, MaSp2+pET19SX, MaSp2+pET19KC, and MaSp2+pET19SXC) were
used to assess if moving the his-tag to the C-termini had any affect on protein production
or to limit protein truncation. The western blots showed that when MaSp2 was produced
in the pET19k and pET19KC vectors there was much lower protein accumulated than
when using the vectors containing the extra tRNAs and SHMT, pET19SX and
pET19SXC (Figure 2-7). Despite there being minimal truncated protein produced in any
of the expression assays using the different vectors, both pET19KC and pET19SXC, the
vectors with the relocated his-tag, did not produce as much MaSp2. After several more
trials and experiments it was determined that moving the his-tag to the C-terminal had no
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beneficial effects on protein production, and, in fact, was detrimental to spider silk
production. Due to this discovery MaSp2+pET19SXC and MaSp2+pET19KC were not
scaled up to the benchtop fermentation, as it was determined this would be a waste of
resources and not beneficial to spider silk protein production.
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MaSp2: 65 kDa

Fig. 2-7 Western blot showing a MaSp2 spider silk protein (65 kDa) production.
Growth assay comparisons between pET19k (wells 1 and 2), pET19SX (wells 3 and 4),
pET19KC (wells 7 and 8) and pET19SXC (wells 9 and 10) with samples taken 4- and 6hours post-induction.

Bench Fermentations and HPLC
To quantify yields and determine the difference in protein production using
pET19k or pET19SX, fermentations were conducted at a benchtop scale with a volume of
1-5 L, depending on the fermentation vessel used. E. coli was harvested and processed on
an AKTA Advant, MaSp2 production was verified with Western blot analyses. The
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AKTA purifications showed MaSp2 was eluted with a significantly higher absorbance
when the pET19SX vector was used, rather than the pET19k (Figure 2-8). Once the
elution fractions were freeze-dried and the protein was verified on a Western blot
analyses it was determined that by adding the gly-tRNAs, pro-tRNA and SHMT present
in the pET19SX vector yields could be increased from 100 mg/L to 500 mg/L, a 5X
increase in production. These results were only based on the fermentations run under the
same conditions listed in the Materials and Methods above, there was no further
exploration into altering fermentation conditions to improve yield conducted for this
particular research project.

MaSp2 + pET19SX: 10 g

Absorbance
(nm)
MaSp2 + pET19k: 50 g

Time (minutes)

Fig. 2-8 HPLC purifications using the AKTA Advant on MaSp2 (65 kDa) in either
the pET19k (50 g cell pellet) or pET19SX (10 g cell pellet) expression vectors. The
overlapped purifications are shown on a graph of absorbance (nm) over the purification
time (s), the peaks represent the protein being eluted from the nickel column and
fractioned into collection tubes.
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Other Work
This research was conducted in 2012-2014 and there has been a significant
amount of research conducted since then on spider silk production in E. coli, some based
on this research’s results. Some further research worth mentioning includes: changes in
the media to increase glucose availability, lowering the temperature at which the
fermentations were performed and using a co-expression system with two different
vectors, one containing the additional tRNAs and the other containing the targeted silk
gene. The field has changed by substantially, researchers can now attain spider silk that
more closely mimics the native silk in properties and size, as well as, attain consistent
yields of greater than or equal to 1 g/L94,113,114. A manuscript is currently in progress from
members of our spider silk laboratory, with Sreevidhya T K, PhD as the primary author.
Conclusion
While there was a lot more research required, some of which has since been
conducted, a commercially viable rSSp process has proven to be attainable in E. coli. By
altering fermentation conditions and utilizing varying vectors to increase tRNA
availability, rSSps can be produced that more closely mimic the mechanical properties
innate to native spider silk. The research conducted for this dissertation alone improved
rSSp yields by five-fold. These extraordinary rSSps can now be produced at 1 g/L in E.
coli fermentations, therefore are now commercially viable products.
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CHAPTER 3
SPIDER SILK PRODUCTION IN AGROBACTERIUM TRANSFORMED
MEDICAGO SATIVA
Chapter Preface
This chapter presents research conducted to develop transgenic Medicago sativa,
more commonly known as alfalfa, that produces recombinant spider silk proteins (rSSps).
Due to alfalfa’s high protein content (24% dry weight), it is a great option for long-term
commercial production of synthetic spider silk. Past research has seen yields as high as
2% dry weight rSSps produced. While most synthetic materials produced in alfalfa are
only peptides (50-100 bp), in this research much larger spider silk genes (2000-6000 bp)
were integrated into the plant’s genome. These genes translate into 80-110 kD rSSps. The
goal of this research project was to create an economically feasible system to produce
rSSps, utilizing alfalfa as the transgenic host.
Using molecular cloning and bioengineering methods an Agrobacterium
tumefaciens mediated transformation was conducted using spider silk genes inserted into
a newly constructed plant tumor inducing vector, MpRI201AN, which was part of this
research and based on the commercially available pRI201AN from Takara ®.
MpRI201AN contains all the necessary DNA elements and tags to increase targeted gene
expression and retain the proteins in the endoplasmic reticulum (ER), which will ensure
that the synthetic proteins will only be expressed in the leaves of the genetically modified
plants. This modified vector not only simplifies the synthetic protein purification process,
but it also removes waste management costs and creates a secondary source of revenue,
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as the stems and other waste from the plants can be used as either feed for livestock or
ethanol production. Unlike the stems and roots, the leaves are much easier to harvest and
process.
During the course of this research issues arose during purification via a Nterminal poly-histidine tag due to the plant’s chlorophylls interacting with the resin
containing the nickel ions used for immobilized metal ion high performance liquid
chromatography (IMAC/HPLC). In order to successfully extract and purify rSSps from
alfalfa, a new purification process was created. In collaboration with Dr. Charles Miller
from Utah State University’s Biological Engineering department, a bacterially derived
synthetic chlorophyllase was used to cleave the phytol tail, the portion of the chlorophyll
molecule that was adversely interacting with the resin of the nickel packed column, from
the chlorin magnesium ring. By conducting a sequential precipitation, the rSSps were
successfully separated from the phytol tail. Whether this enzymatic reaction combined
with an alcohol/salt precipitation is sufficient to produce a pure enough synthetic protein
is yet to be seen. The synthetic protein may still need to be further processed to ensure
purity, either through ammonium sulfate precipitations or HPLC. We have hypothesized
that HPLC will prove unnecessary and the purified rSSps can be attained through
ammonium sulfate precipitations. It should be noted that each additional step added to the
purification process causes a decrease in yield, due to rSSp loss in each step. These issues
will need to be analyzed and possibly addressed if proven significant, via downstream
processing methods to create a viable production process in alfalfa.
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As has been observed in bacterially derived spider silk, alfalfa derived spider silk
does not store well when frozen, rendering the rSSps completely insoluble that make
extraction and purification, as of yet, impossible. Due to this and some other unforeseen
issues with machinery malfunctioning and plant health issues, a pure rSSp and
quantifiable yield has not been obtained. Currently new plants are in development
including: 1) a MaSp2 + C-term plant, which is the protein that is used throughout this
research and 2) 3X and a 12X aggregate silk protein plants.
This research lays the groundwork toward creating transgenic alfalfa plants
capable of producing native-sized spider silk proteins at a commercially viable yield.
This current and future research is being conducted to produce a successful rSSp
production process using alfalfa as the genetic host and answer questions into the
production processes’ feasibility for long-term production system.
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Introduction
Medicago sativa, more commonly known as alfalfa, is a perennial crop that can
be harvested in most locations four to ten times a year and has been utilized as a genetic
engineering host since the 1980s with great success, producing many different synthetic
proteins and peptides at a high yield115. Alfalfa was approved by the USDA more than a
decade ago as an appropriate transgenic host for synthetic protein and peptide production.
Companies, such as Medicago® and Forage Genetics®, currently grow transgenic fields
for commercial product95–97,99,116–119. Total protein content in alfalfa is up to 24% dry
weight, and past research has shown yields of up to 5% dry weight synthetic protein.
Other attributes that make alfalfa desirable as a host for synthetic protein production, is
that it has no common relatives and, therefore, cannot cross-breed with any other plant
species120. A buffer area of 50 feet has proven to adequately ensure that the synthetic crop
is isolated from other non-genetically modified alfalfa fields; this is due to the area of
cross-pollination that is inherent to alfalfa. Our laboratory has determined that a 2% dry
weight spider silk yield in alfalfa would produce 218 kg protein per acre per year, a yield
that supports commercialization (Table 3-1).
Table 3-1 A comparison of synthetic spider silk protein production hosts, current
predicted yields and measured rSSp sizes
System
Bacteria
Goats
Silkworms
Alfalfa

Comparison of Protein Yields
Protein Yield
Protein Size (kDa)
3 kg per 30,000 L
50-70
18 kg per goat per year 65
2-5% spider silk
80-240
218 kg per acre per
80
year
Data from Randolph Lewis Laboratory
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An added benefit is that all spider silk protein will be produced in the leaves, so
the “waste” can be used as either livestock feed or for ethanol production, which are
already developed processes in alfalfa98,121. These two processes essentially eliminate all
waste removal costs associated with synthetic protein production and provide a secondary
source of revenue. Alfalfa is also hypothesized to be capable of producing the large (200350 kDa) and highly repetitive spider silk proteins without premature translational
termination, since some native alfalfa proteins are of a similar size.
A few attempts have been made to produce spider silk-like proteins in
plants68,69,122. Recombinant silk proteins were produced in potatoes and tobacco, but they
were not purified or mechanically tested, and they were small monomers of only ~35
kDa. Production in alfalfa provides a much more promising system for recombinant
spider silk proteins (rSSps) than other plants that have been utilized due to its’ high
protein content and previous synthetic protein production approvals through the USDA.
The main focus of this research project was to improve rSSp yields and create a
long-term commercially sustainable process for synthetic production by implementing
spider silk genes into alfalfa. Spider silk genes were inserted into alfalfa’s genome via an
Agrobacterium tumefaciens mediated transformation using an in-house Ti vector,
MpRI201AN, of alfalfa cultivars. A poly-histidine tag, other various protein expression
tags and regulators were cloned into a new expression vector to amplify protein
expression, ease purification techniques, and cause targeted rSSp expression. The rSSps
will be retained in the endoplasmic reticulum of the cells, ensuring that vast majority of
expressed protein will be present in the leaves and not in the stems or roots of the plants.
The theory for this research was that a new production method for rSSps could be created
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that would improve yields and expand rSSp production capabilities, by expressing native
sized synthetic proteins that would have improved mechanical properties.

Materials and Methods
Cloning
For this research a new expression vector was created with the ability to transform
into both E. coli and A. tumefaciens, and ensuring that targeted genes would be retained
in the endoplasmic reticulum (ER), causing the protein to only be expressed in the leaves
of the transformed cultivars. Some modifications that needed to be added to the
commercially available pRI201AN from Takara ® were: 1) the two multiple cloning sites
needed to be combined into one multiple cloning site that would contain both a NdeI site
on the N-term and a BamHI site on the C-term, as these are the sites used for cloning of
all in-laboratory rSSps, 2) the 5’ end of the vector, upstream from the NdeI site, needed
to contain a Leb 4, His6-tag, Xpress Epitope, while retaining a viable NdeI site, so the
enzyme used in the adaptor needed to be compatible/nonregenerable to NdeI in this case
the MseI restriction endonuclease was utilized, 3) a Gly-Lys-Lys-Gly sequence was
added between the Leb 4 and his6-tag, to address any purification issues and 4) the 3’ end
of the vector, downstream from the BamHI site, needed to contain ELP repeats, KDEL, a
SacI site, and a KpnI site so that a HSP (heat shock protein) terminator could be
integrated there (Table 3-2 and Figure 3-1). These N-term and C-term adaptor sequences
were codon optimized for Medicago sativa and synthesized (Life Technologies).
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Table 3-2 List of tags and sequences necessary for Agrobacterium transformation
into Medicago sativa that will result in targeted protein production in the leaves of
the transgenic plants. The name of the sequence and their function within the vector and
plant are described.
TERM

FUNCTION
A promoter from the cauliflower mosaic virus. It is a very powerful
Cam35S
promoter and is not greatly influenced by environmental conditions or
promoter
tissue types
Heat shock protein derived terminator that allows for higher target gene
expression. Has a higher expression rate than the traditional NOS
HSP terminator terminator
Leb 4
Permits the translocation of the protein to the endoplasmic reticulum
Xpress Isotope Helps increase protein expression
ELP repeats
This is used as a tag and also increases protein expression
This causes the protein to be retained in the endoplasmic reticulum.
Research has shown that ER retention allows the most protein to be
KDEL
accumulated
Removes the N-term with trypsin. Backup plan for if the N-term causes
Gly-Lys-Lysproblems with protein purification and/or alters the spider silk protein’s
Gly
properties

N-term Insert:
5’

TTAAATGGCTTCCAAACCTTTTCTATCTTTGCTTTCACTTTCCTTGCTTCTCTTTACAAGCACATGTTTAGCA
GGAAAAAAGGGACACCATCACCATCACCACGATCTTTATGATGATGACGATAAGCATATG3’
Leb 4
Gly-Lys-Lys-Gly
His6-tag
Xpress Epitope Tag
C-term Insert:
5’

GGATCC(GTTGGTGTTCCTGGA)5AAAGACGAACTCTAGGAGCTCTAGGGTACCGAATTC3’
ELP repeats
KDEL stop

Fig. 3-1 N- and C- term adaptors synthesized by Life Technologies. These amplify
targeted protein production and cause the synthetic proteins to be retained in the
endoplasmic reticulum, therefore the leaves, of the alfalfa plant.

The N- term adaptor was cloned into pRI201AN by first digesting both the
pRI201AN vector and the N-term adaptor with the restriction enzymes MseI and NdeI,
and then ligating the vector and adaptor together using a T4 DNA ligase (New England
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Biolabs M0202S); the resulting ligations were electrotransformed into XLBlues at
1800V. Ultimately, these transformations proved unsuccessful. It was determined that
because the MpRI201AN DNA was so large, 10,719 bp total, that any cloning to occur to
build and design the vector or to insert genes into the expression vector once it was
constructed needed to be treated differently. Due to folding issues within the DNA pieces
used to build the vector 0.2% DMSO was added to the ligation mixture and, to slow the
ligation down, it was conducted on ice for 15 minutes, rather than at room temperature
for 10 minutes. These changes in the ligations still did not yield any successful clones,
despite showing the correct ligation upon enzymatic digestion checks on 0.8% agarose
gels.
Ultimately, another variation of competent cell was needed that was specifically
for building and transforming large (≥10,000 bp) constructs: chemically competent β-10s.
These proved far more successful when transformed with the ligated pRI201AN and Nand C-term adaptors, as well as any further cloning within the newly built MpRI201AN.
Once clones with the N-term adaptor were screened and verified, the C-term was inserted
into the BamHI and EcoRI restriction enzyme sites through the same process. The new
vector was named MpRI201AN and verified via DNA sequencing.
This research was a continuance of research conducted at the University of Wyoming by
Holly Steinkraus. During the prior research a MaSp2 16-mer was inserted into the BamHI
and NdeI sites of an expression vector, R111, obtained from Forage Genetics®, this
construct was electrotransformed into XL1-Blue Supercompetent Cells
(Agilent/Stratagene C2992) at 1800V (Figure 3-2). Once the plasmid was verified via
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DNA sequencing it was electrotransformed into LBA4404 Agrobacterium competent
cells (Thermo Fisher Scientific 18313015). Upon successful transformation into
Agrobacterium, the cells could then be used to agrotransform alfalfa.

5’

AAGCTTGGATCCCACGCC(GGCCCGGGTAGCGCTGCCGCAGCGGC
AGCTGCAGCTGGACCTGGGGGCTATGGACCAGGTCAACAGGGAC
CAGGAGGTTACGGTCCTGGCCAGCAAGGTCCTTCC)16GGAGATGAT
GACGATAAGTCTAGAGGATCCACTAGT3’
Fig. 3-2 Nucleotide sequence for a synthetic major ampullate spidroin (MaSp2) with
a conserved C-term sequence. Nucleotides in red represent the repeated monomer, this
monomer is repeated 16X making this sequence a 16-mer.

Other rSSp genes that were ligated into the BamHI and NdeI restriction enzyme
sites of MpRI201AN included: 3x aggregate + linker, 9X aggregate + linker, 12X
aggregate + linker, and (MaSp2)16 + C-term. All spider silk sequences were extracted
from their base vectors (pMK or pBluescriptII) by digesting with BamHI and NdeI
restriction enzymes from NEB and then running gel electrophoresis on a 1.2% agarose
DNA gels at 50V for 1 hour to separate the cut plasmid and the targeted inserts were cut
out with a razor blade. A QIAquick gel extraction kit (QIAgen 28704) was used to extract
the DNA from the gel slices according to company protocol.
Agrobacterium transformation and Medicago sativa Cell Culture
Alfalfa agrotransformation protocols were obtained from Forage Genetics
International. The appropriate strain of Agrobacterium (LBA4404, ElectroMAXTM A.
tumefaciens Thermo Fisher Scientific 1810315) was streaked out on a plate of YEP
(10g/L Peptone, 10 g/L yeast extract, 5 g/L NaCl with 50 µg/mL kanamycin) and
incubated at 28°C for 2-3 days. At 12 pm the day before transformation a flamed loop
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was used to scoop up 2-3 colony forming units and grown overnight in 125 mL YEP
flask, shaking at 27-28°C and ~200 rpms. The OD660 was checked before transformation,
typically a healthy OD660 should be approximately 1.4-1.5. Agrobacterium was pelleted
for 10 minutes at 3700 rpm in a 50 mL tube. 40 mL room temperature 1/10th SHDN
(Macronutrients, micronutrient’s, iron-EDTA, vitamin, sucrose, agar 2,4 D and kinetic)
bacterial resuspension media was used to resuspend the cells.
1 mL of liquid SHO (Iron-EDTA, alfalfa vitamins and nutrients, sucrose and agar)
was pipetted directly onto the SHDN (SHO, 2,4-D, and Kinetin) plate and a sterile
Whatman filter paper was placed on plate. Using forceps and a sharp scalpel, leaves were
removed from R2336 box plant (Forage Genetics) and put into the Agrobacterium. The
leaves were sliced into 2-3 mm pieces, blotted on the Whatman paper and transferred to
paper-lined SHDN plate (40-50 pieces/plate) with no antibiotic selected. Plates were
sealed with masking tape and incubated at 25-26°C, without light, for 3 days.
After 3 days, the plants were transferred to SHDN + Timentin (150 µg/mL). If
overgrown with Agrobacterium they were washed with Timentin. After another 3 days,
the explants were thinned to 20-25 per plate. Plates were thinned as calli grow to 10-15
per plate, depending on their size. This is the point when kanamycin is added to the plates
at 50 µg/mL. After 6 weeks growth if plants are clearly dead, they are discarded. Callus
starts to develop green buds or embryos and at this point they are transferred to
regeneration or induction media containing hormones to promote leaf and root
development. Embryos are separated from the campus after 2-3 weeks (Figure 3-3 A).
After three additional transfers on kanamycin selective media well-developed embryos
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were transferred onto SHO Timentin (50 µg/mL). Now embryos are transferred to new
media every two weeks. Once roots were sufficiently developed the plantlets were
transferred to magenta boxes containing SHO Timentin (100 µg/mL) (Figure 3-3 B).
Rooted plants were transferred to soil and maintained in a Conviron standing incubator.
Optimal conditions include: 25°C, 16 hours light and humidity.

A

B

Fig. 3-3 Photographic images of the stages in alfalfa plant cell culture. A) Is a picture
of a developed Agrobacterium transformed callus that has started to develop leaves and
roots due to growth hormone stimulation. B) Shows a fully developed alfalfa cultivar in a
magenta box of a transgenic plant containing the MaSp2+C-term protein/gene in the
leaves.

Western Blot Analyses
All Western Blots conducted in this research to determine protein production, for
both rSSps and chlorophyllase followed the following protocol: 35 µL loading samples
were prepared with a 1:1 of protein sample to be analyzed to 2XSABU, samples were
boiled for 10 minutes in a water bath and then loaded onto a 4-20% tris-glycine SDS-
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PAGE gel (Invitrogen XP04200BOX) and run at 135 V for 90 minutes. Gels were
transferred to nitrocellulose membranes overnight in a 4°C freezer room on ice at 25 mA
in a wet transfer apparatus. The blots were conducted on the nitrocellulose membranes
with a primary antibody produced in mice that targets the histidine tag (Rockland 200303-382, 1:1000 dilution). A rabbit anti-mouse antibody conjugated with Alkaline
Phosphatase (AP) was used at a 1:5000 dilution (Abcam ab6729). The membranes were
developed using 1-StepTM NBT/BCIP Substrate Solution (Thermo Fisher Scientific
34042) for imaging.

Purification
Leaves were harvested from transgenic alfalfa plants manually and stored in
Ziploc ® bags at -80°C. In order to extract the proteins, the leaves were ground up using
a mortar and pestle in a 1:3 (wt/v) binding buffer (8M Urea, 20 mM Tris-HCL, 0.5 M
NaCl, 2 mM EDTA). Three freeze (-80°C for 10 minutes), thaw and grind cycles were
conducted to homogenize the plant cell tissue adequately. The ground plant material was
centrifuged at 16,000 rpms for 30 minutes and the cell lysate (supernatant) was taken off
the plant cell tissue pellet as the cell lysate. This process was repeated until the cell lysate
was confluent or clear of all solid plant material, on average four times. When done at
room temperature there was inadequate tissue emulsification, leading to a lot of solid
plant tissue that wasn’t processed. After some experimentation a freeze/thaw cycle was
concluded to lead to the best plant tissue processing method, with no solid pieces of plant
tissue present after the final cycle. Three freeze (-80°C for 10 minutes), thaw and grind
cycles were conducted to fully homogenize the plant cell tissue adequately.
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Originally, it was believed that this alfalfa cell lysate could be purified using the
poly histidine tag, so purification was attempted using immobilized metal affinity high
performance liquid chromatography (IMAC-HPLC). An AKTA Avant was used with NiNTA resin (GE XK-16, bed height 14 cm). The sample was applied to column at 1
mL/minute and clarified lysate was applied across the column from both the top and
bottom. Halfway through all attempts to purify using this strategy the pressure would get
so high in the column that the run would automatically abort. The Ni-NTA resin would
turn completely green, the exact color of the chlorophyll in the plant extracts, and all
efforts to remove the attached chlorophyll molecules were unsuccessful and it was
determined that in order to purify rSSps from alfalfa the chlorophyll molecules would
have to be removed from the cell lysate prior to any processing and purifying using
HPLC.
Chlorophyllase Production and Purification
After much literary research and thought it was determined that the reason the
chlorophyll was interacting with the Ni-NTA resin was because of the phytol tail portion
of the chlorophyll molecule. Several chlorophyll removal processes were considered as
options, including: chemically removing chlorophyll, precipitating the alfalfa cell lysate
to separate the chlorophyll from the protein, size exclusion chromatography and an
enzymatic reaction that would cleave the phytol tail of the chlorophyll molecule from the
chlorin ring. The chemical removal of chlorophyll from the protein lysate was determined
to be too expensive to upscale, due to chemical costs and waste removal costs, since
some of the chemicals used in this reaction are non-reusable and very caustic. The
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precipitation option turned out to be a fruitless option, as the rSSp would end up in the
same phase as the chlorophyll due to their similar charges and other characteristics. Size
exclusion chromatography was also not a valid option, since there are some rSSps that
are similar in size to that of the chlorophyll, ~250-300 kDa. It was decided that using an
enzyme to break up the chlorophyll molecule was the best route and fortunately, Dr.
Charles Miller from the Biological Engineering Department at Utah State University had
just concluded an IGEM project that cloned a synthetic chlorophyllase (TaChl) into an
expression vector for production in E. coli. The TaCHL is a chlorophyllase enzyme from
a common wheat species and is a 37 kDa enzyme that has a histidine tag and can,
therefore be purified using IMAC123.
This chlorophyllase (TaCHL) acts by cleaving the chlorophyll molecule into two
subunits: the chlorin magnesium ring and the phytol tail. In order to remove the
chlorophyll molecules from the alfalfa cell lysate, deterring any interactions with the
charged rSSps and HPLC purification, an enzymatic reaction was conducted followed by
an alcohol precipitation.
This synthetic chlorophyllase was produced in a 1 L E.coli flask culture. The
culture was inoculated with 1 colony forming unit from a chloramphenicol (50mg/mL)
agar plate containing the synthetic chlorophyllase construct. Cultures were grown in 1L
LB Broth media (Miller 71753-6) and selection was conducted with chloramphenicol (50
mg/mL). Flask cultures were grown until an OD600 of 0.8 was reached and then
expression was initiated with 1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) and
cultured an additional 4 hours. Cells were harvested from the flask culture by
centrifuging at 6000 rpms for 30 minutes and the cell pellet was processed in an 8M Urea
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binding buffer (8M Urea, 20 mM Tris-HCL, 0.5 M NaCl, 2 mM EDTA) at 1:3 weight to
volume dilution. Sonication was conducted on ice at 1 W for 4 minutes, followed by a
minute rest, and this process was repeated 3 times (QSonica ¾” diameter probe). The cell
lysate was harvested through centrifugation at 6000 rpms for 30 minutes, retaining the
supernatant as the final cell lysate.
Protein purification was conducted using immobilized metal affinity high
performance liquid chromatography (IMAC-HPLC) utilizing the polyhistidine (6X) tag
on the TaChl (35 kDa) constructs, either at the N- or C-terminus depending on the vector.
An AKTA Avant was used with Ni-NTA resin (GE XK-16, bed height 14 cm). Sample
was applied to column at 1 mL/minute and clarified lysate was applied across the column
from both the top and bottom, separately to ensure complete application. The column was
washed with running buffer (0.5 M NaCl, 20 mM Tris-HCL, 0.5 mM EDTA) and wash
fractions were collected. 5 mL elution fractions were collected for 3 column volumes at
5%, 10% and 100% imidazole. Samples of these fractions were mixed 1:1 with 2X
SABU with 6 M Urea and heated for 15 minutes at 100°C. These samples were analyzed
by SDS-PAGE and western blot as described above to verify protein purification.
Chlorophyllase Reaction
Attempts were made to separate the chlorophyll, or at least the phytol tail portion
that was causing issues with rSSp purification, from the alfalfa derived rSSp. Synthetic
chlorophyllase (TaChl) was combined with the protein lysate, and in order to induce
enzymatic activity of the TaChl 1:1 acetone:water was added to the solution and shaken
at 2500 rpms, to ensure distribution, at 37°C, which is the optimal temperature for the
chlorophyllase enzyme. After 30 minutes of enzymatic activity a precipitation was

61

conducted at room temperature using two volumes 3:4 (heptane:acetone). Separation was
aided by centrifuging the reactions for 30 minutes at 3500 rpms. This precipitation was
conducted in glass vials or glass capped tubes due to the erosive nature of heptane. At
this point the chlorophyllase had enzymatically cleaved the phytol tail from the chlorin
magnesium ring and the two resulting molecules had been separated by precipitation into
different phases. Two controls were used to verify that rSSp separation was due to the
chlorophyllase reaction, and not just the precipitation: 1) a precipitation control with no
alfalfa lysate and 2) an alfalfa lysate precipitation with no TaChl (Figure 3-4). This
particular precipitation protocol was used because, despite heptane being a harsh
chemical it is reusable and is contained in the upper phase of the precipitation. The
heptane can be decanted off of the other two phases and placed in a glass vial until
needed for the next precipitation.
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Precipitation

(-) control

Alfalfa Lysate +
Chlorophyllase

H2O + Chlorophyllase

Alfalfa Lysate + Precipitation

700 µL alfalfa lysate + 300 µL
TaChl

700 µL H2O + 300 µL TaChl

700 µL alfalfa lysate + 300 µL
H2O

TaChl (Ch)

Add 1 mL acetone and shake
at 37°C for 30’.

Add 4 mL acetone:heptane (3:4) and
centrifuge at 3500 rpms for 30’.

Separate into phases
and lyophilize.

Fig. 3-4 Flow diagram showing the chlorophyllase experiment progression conducted on
alfalfa protein lysate containing the synthetic MaSp2.

The phases were separated into an upper phase, which includes the heptane and
phytol tail portion of the chlorophyll molecule, an intermediate phase, where the chlorin
magnesium ring would separate into, and a lower phase, where it was theorized that the
rSSps would precipitate to. These separated phases were dried overnight, until all liquid
was removed, and resuspended in 200 µL 2X SABU. All samples were analyzed using
the western blot analyses protocol listed above, to determine which phase the rSSp
precipitated into.
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Results and Discussion
The MaSp2+C-term plants originally from University of Wyoming were tested by
extracting protein from the alfalfa and running the lysate across an SDS-PAGE gel and
analyses on a nitrocellulose membrane via western blot analyses. The MaSp2+C-term is
an ~80kDa protein and was shown to be present in the Agrobacterium transformed plants
that Holly Steinkraus had made (Figure 3-5). Now that we had proof that a spider silk
protein was being produced in the alfalfa plants, a purification process and yield
determination were needed.

1
(-)

2
MaSp2+C

3
(+)

4
Ladder

Fig. 3-5 Western blot showing a MaSp2 spider silk protein with a C-term (80 kDa).
Proteins were produced and crudely extracted from a transgenic alfalfa plant in an 8M
Urea buffer (well 2), in comparison to a plant cultivar that has not been transformed (well
1) and a positive his-tag spider silk produced in E. coli (well 3).
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All purification attempts on the AKTA Avant (HPLC) with the cell lysate caused
the nickel columns to be bound and clogged up by the chlorophyll molecules, causing the
columns to turn green, and ultimately the program would auto abort due to the increase in
pressure. Once the columns were bound up with the chlorophyll, we were unable to
recover the spider silk or clean the columns with any amount of treatment with imidazole
or other solvents. We were not only unable to obtain any spider silk protein from this
purification method, but we were also ruining hundreds of dollars of materials upon each
attempt. At this point in the research an alternative purification method was needed and it
was decided to utilize a chlorophyllase enzyme to break apart the chlorophyll molecule,
followed by a precipitation to separate the two chlorophyll components from the spider
silk proteins.
Chlorophyllase experiments yielded three different phases for the chlorophyllase
reactions and two phases for the precipitation controls. In the chlorophyllase reactions the
upper phase or layer consists of the heptane and, if successfully removed in the
chlorophyllase reaction, the phytol tail, the intermediate phase contains the alcohol and
chlorin ring of the cleaved chlorophyll, and the lower phase is all the precipitates.
Visually the precipitations of the different experiments show that when the
chlorophyllase is used there is a definite alteration in the color of the upper and
intermediate phases, versus the experiment with no enzyme; this is a good visualization
that the enzyme was working (Figure 3-6). In order to determine if this color difference is
actually a response to TaChl activity and separation of the phytol tail, chlorin magnesium
ring and the rSSp a western blot analyses was conducted on the lyophilized phases
resuspended in 2XSABU. Western blot analyses showed the presence of the TaChl (35
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kDa) as a positive control and in the intermediate phases of the enzyme and no enzyme
reactions and the lower phase of the precipitation control. The MaSp2 + C-term is
precipitated into the lower phase of both the chlorophyllase and no chlorophyllase
precipitations (Figure 4-7). Since we know that the phytol tail remains in the heptane
upper phase and the chlorin magnesium ring precipitates to the intermediate phase, and
the rSSp shows up in the lower phase, this means that the rSSp has been effectively
separated from the chlorophyll, specifically the phytol tail that interacts with the nickel
column during HPLC.

A

B

C

Separate into phases

No Enzyme

Chlorophyllase

U

I

L

U

I

Precipitation

L

U

L

Fig. 3-6 Chlorophyllase experiments conducted on alfalfa plants containing
MaSp2+C spider silk protein. A) A chlorophyllase reaction conducted on a plant protein
extract with a precipitation, B) a negative control that was just a precipitation on a plant
protein extract containing heptane, but no enzyme, and C) a precipitation control with no
heptane added and no chlorophyllase reaction. The precipitations were separated into
phases designated U (upper phase), I (intermediate phase) and L (lower phase).

Some issues arose with mold contamination of the spider silk cultivars and a
power surge in the incubator that caused the lights to stay on 24-hours a day rather than
following the program caused all original MaSp2 + C-terminal plants to wilt and
eventually all died before the issues could be addressed. Efforts are being made creating
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new MaSp2 and MaSp1 spider silk plants that will take 6 months to go to soil once the
genes are successfully agrotransformed into R2336 trifoliates. Also, now that 3X
aggregate has been integrated into the MpRI201AN vector and 6X, 9X and 12X
aggregate are currently being cloned into the MpRI201AN transformation vector, new
spider silk plants with rSSps that are similar in size to native spider silk proteins will be
agrotransformed into alfalfa cultivars soon by future members of the laboratory.
Another setback that has occurred, is that much like is the case in E. coli produced
rSSps, the rSSps become insoluble over time when the leaves are stored at -80°C. Efforts
have been made to solubilize the rSSps, including: altering the binding buffer used to
contain a higher concentration of Urea, EDTA, etc., after the leaves were grinded in the
binding buffers they were subjected to sonication and microwaving before being further
processed by centrifugation and 2% Sarkosyl was added to the 2XSABU used for
western blot analyses. None of these attempts were successful in solubilizing the rSSp.
rSSp presence is known to be in these specific plants, because past research and western
blot analyses have shown this, but they are as of now undetectable and unobtainable.
These findings have stalled efforts in defining a rSSp yield and obtaining a pure protein
product from the alfalfa. While this is unfortunate, the efforts listed above at creating new
plants agrotransformed with rSSps are currently being performed in an effort to develop a
yield and define a purification process.
Future Research
Future research should include the Agrobacterium transformation of other rSSps
into alfalfa, namely spider silk genes of varying size and type. One spider silk protein that
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would be of particular interest, is aggregate. Aggregate is a glycosylated glue-like spider
silk protein that has previously been produced in Spodoptera frugiperda (SF9 cells), and
due to alfalfa’s innate ability to post-translationally modify proteins to be glycosylated,
could be successfully produced in alfalfa at a much higher yield and lifetime production
than in the SF9 cells.
Other interesting rSSps would be any that are on the same size scale as those that
are native silks, 250-500 kDa. While other rSSp hosts have produced novel proteins, with
mechanical properties in-line with those found in native silks, none have produced them
on the same size scale. Since spider silk’s mechanical properties are directly related to the
size4, and therefore quantitative repetitiveness of the mechanical characteristic’s motifs,
the rSSps with the same size should inherently have superior mechanical characteristics.
The mechanical characteristics currently exhibited by rSSp products are due to postproduction manipulations, so in theory, if proteins more closely mimicking the native
proteins are created then the products will be far superior to those that are smaller rSSps.
Conclusion
This research has shown, for the first time, that rSSps can be successfully
produced in alfalfa. By genetically engineering a new expression vector and creating a
downstream process for purification, spider silk is now being produced in alfalfa and a
long-term commercially viable production system is on its way to being characterized. A
protocol was developed and tested to separate the rSSp from the chlorophyll, and for the
first time a synthetic protein was separated from the chlorophyll in the alfalfa, utilizing a
synthetic chlorophyllase enzyme and precipitation. Efforts are being made to determine a
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rSSp yield. A publication is in the works and the only data needed to finalize is a rSSp
yield from the alfalfa. Overall this research has shown that large rSSp can be successfully
produced and extracted from alfalfa.
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CHAPTER 4
EUKARYOTIC CELL CULTURE PRODUCTION OF GLYCOSYLATED
AGGREGATE SPIDER SILK PROTEINS IN SPODOPTERA FRUGIPERDES

Chapter Preface
The following chapter describes the production of synthetic aggregate spider silk
proteins in the fall army worm, Spodoptera frugiperdes (SF9 cells), using eukaryotic
adherent cell culture techniques and in Escherichia coli. The aggregate spider silk protein
is a glue-like protein that forms into droplets dispersed across the spider’s web, and
functions as an adhesive assisting in prey capture. Like many naturally occurring
proteinaceous glues, aggregate is a post-translationally glycosylated protein.
Aggregate silk proteins have never been synthetically produced or purified in
their natural glycosylated state. Researchers have shown a direct correlation to
“stickiness” or the glue-like adhesion properties in proteins via glycosylation. Due to this
knowledge, we deemed it necessary to create a glycosylated synthetic aggregate silk
protein that would more closely mimic the native aggregate glue-like protein. As there
are no prior studies creating glycosylated spider silk proteins, a new production process
was necessary.
In order to create a synthetically derived aggregate protein that has N- and Oglycosylation, a production system was needed that had the capability to engineer these
post-translational modifications. Spodoptera frugiperdes was chosen as a host to create
these glycosylated spider silks, due to its’ ease of culture and inherent capability to posttranslationally modify proteins. In order to compare and contrast the mechanical
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influence glycosylation lends to aggregate silk, the synthetic aggregate proteins were also
expressed and purified from Escherichia coli, which is a common production method for
recombinant spider silk proteins (rSSps), but does not post-translationally modify
proteins to be glycosylated.
Spodoptera frugiperdes SF9 cells were used as the cell culture line to produce the
glycosylated aggregates, and the bac-to-bac baculovirus transfection system was used to
create a recombinant cell line containing the genes for the aggregate silks. Using an
aggregate spider silk DNA sequence, plus a linker and C-terminal, which is highly
conserved within all spider silks and among different species of spiders, a synthetic
sequence was synthesized by LifeTechnologies ®. Four different synthetic sequences
were then cloned, ranging from a 3X repeat of the monomer sequence to a 12X repeat of
the monomer. These synthetic aggregate DNA sequences were cloned into the
baculovector pOET2 and the resulting plasmids were used to transfect SF9 cells using the
bac-to-bac transfection system. The infected SF9 cells were grown to create viral titers,
which were then used to infect other SF9 cells that would in response produce the
synthetic aggregate proteins under the correct culture parameters. Glycosylation of the
aggregate proteins were determined upon treatment with a deglycosylation kit and
subsequent analysis via Western blot and also by comparison to bacterially derived
synthetic aggregate proteins.
The research presented in this chapter shows that synthetic aggregate spider silk
proteins can be produced utilizing eukaryotic cell culture in SF9 cells. Evidence is also
shown indicating that the synthetic aggregate proteins are glycosylated. A purification
process utilizing a histidine tag and IMAC/HPLC is presented, as well as, some
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difficulties that arose in purifications due to the aggregate protein being retained within
the SF9 cells. The overall aim of this research was to create a novel synthetic aggregate
protein that was glycosylated, purify the protein and create materials that could be
mechanically tested, so that the strength of the synthetic aggregates could be determined
and compared to those of other glues.
Research towards this project is ongoing, with aims towards defining a yield and
creating testable glues using the synthetic aggregate proteins. Both the SF9 cell produced
glycosylated aggregate and the bacterially derived non-glycosylated aggregate will then
be mechanically tested and compared to the mechanical characteristics of both common
glues and other synthetic spider silk glues. It is important to note that while aggregate
production in SF9 cells is currently advantageous for bench top research and material
characterization, there may be insurmountable yield issues when scaling up to a
commercially viable level that will require an alternative production system also capable
of post-translationally glycosylating proteins. While the research presented in this chapter
is mostly a preliminary expression system as a proof of concept for synthetic aggregate
production, it is essential to future research to mass produce aggregate spider silk proteins
for material development and subsequent material testing.
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Introduction
Among orb-weaving spiders there are two different methods that add stickiness to
the web, allowing for prey capture and lashing different silks together124. Cribellate silk is
extruded onto the web, specifically the capture spiral, and aggregate silk proteins are
secreted onto the web as droplets. Cribellate silk forms into bundles after being extruded
from the cribellum and acts as a core fiber in pseudo-flagelliform silk. Cribellate silk is
very elastic and, despite the core fiber rupturing at moderate extension, the rest of the
bundle can extend to 500% of its original strength while maintaining fiber integrity125.
Over time spiders have evolved from using cribellate capture threads to adhesive capture
threads containing aggregate protein126,127. This is due to aggregates superior adhesion
properties allowing greater prey capture potential128,129.
Aggregate proteins are secreted as droplets forming a coating on flagelliform silk.
The size and density of the droplets is dependent on the species of spider. At the center of
each aggregate protein droplet there is a granule, which was originally thought to contain
the glycoprotein glue responsible for the adhesive characteristics seen in aggregate55.
This was later disproved and it was theorized that the aggregate silk proteins form three
layers: 1) the granule, which serves as an anchor for the protein, 2) an aqueous coating,
and 3) a glycoprotein layer54,57,126.
Aggregate proteins are particularly interesting due to their ability to vary the
Young’s Modulus depending on both the relative humidity and the speed with which the
fiber is stretched. Aggregate proteins have a higher stress at a 40% relative humidity
(RH) and lower stress at 15% and 90% RH130–132. This makes aggregate spider silk
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proteins highly desirable with their ability to still have a high adhesion in aqueous
conditions. Of particular interest are underwater adhesives, since currently there is not a
commercially available aquatic glue available, and surgical glues, as spider silk has been
shown to be biocompatible and biodegradable2,10,12,133,134.
Synthetic aggregate silk has never been produced and only recently has the
nucleotide sequence been elucidated58. Based on what is known of naturally occurring
glues and adhesives, it can be surmised that glycosylation of the aggregate proteins is a
driving factor in stickiness characteristics. A host system was needed to create synthetic
aggregate proteins that were post-translationally modified to be glycosylated. As
Escherichia coli, a common production system for synthetic spider silks, is not capable of
these modifications, another fast production system was needed for research into
aggregate production135.
Spodoptera frugiperdas (SF9 or SF21 cells) is the larval life stage of the fall army
worm and has been used in eukaryotic cell culture for years to produce synthetic proteins,
even to produce some recombinant spider silk proteins (rSSps)136. The novelty in
production via SF9/21 cells comes in the relative ease of culturing, fast generation time
and, of particular interest for this research, the ability to post-translationally modify
proteins, such as with glycosylation93.
In this research SF9 cells were transfected using the bac-to-bac system to contain
various synthetic aggregate genes. The synthetic proteins were expressed, purified and
verified using western blot analyses and Coomassie staining of SDS PAGE gels. The
findings in this study establish a production method for synthetic aggregate proteins that
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are post-translationally modified to be glycosylated on the N- and O- sides of the amino
acids. Studies are ongoing to define a yield and create products containing both
glycosylated aggregate and non-glycosylated aggregate to compare and contrast their
mechanical characteristics.
Synthetic aggregate genes were also inserted into an E.coli expression vector,
pET19KT, and the rSSps were expressed in flask culture. These synthetic proteins would
not have any post-translational modifications, namely glycosylation, and could, therefore,
be used as a comparison to the SF9 cell derived rSSps. Both the size (kD) and the
mechanical characteristics should be altered when glycosylation is present.
Materials and Methods
Cloning
For this research aggregate DNA sequences based on the research conducted by
Hayashi et.al were used to create synthetic monomers with a linker and highly conserved
C-terminal sequence 58. The synthetic aggregate monomers were synthesized by Life
Technologies®. Four iterations of the aggregate monomer were desired: a 3X aggregate
(3 repeats of the monomer sequence and a linker), 6X aggregate, 9X aggregate and 12X
aggregate. In order to clone these sequences compatible non-regenerable sites were
used22. Specifically, NdeI/AgeI and BspEI/XhoI restriction endonucleases were used.
Aliquots of isolated plasmid were digested with NcoI and AgeI or NcoI and BspEI. The
digests were run on an agarose electrophoresis gel at 50 V for 90 minutes to ensure band
separation and the desired bands were extracted and purified using a gel extraction kit
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(QIAgen 28704). Using T4 DNA ligase the two extracted bands were ligated together
(Thermo Fisher Scientific EL0011). Upon ligation the resulting plasmid should have 6X
repeat of the aggregate repetitive region (Figure 4-1).

Fig. 4-1 Formation of the 6X aggregate repetitive region. The respective aggregate
monomer is in red. The figure shows destruction of the AgeI and BspEI sites during
ligation. Red arrows indicate the gel electrophoresis bands that represent the specified
sequences. Segments excised and purified are circled in red. Reprinted with permission
from Kyle Berg.

Using the same cloning scheme, a 9X aggregate sequence was made from a 3X
aggregate monomer + 6X aggregate polymer, and a 12X aggregate sequence was made
from two 6X aggregate polymers cut with the same enzyme combinations (Figure 4-2).
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All plasmid constructs were verified via digestion with BamHI and NdeI, as well as DNA
sequencing. Once clones were verified, the aggregate sequences were cloned utilizing the
KpnI and BamHI sites in pOET2 (Oxford Expression Systems 2001031), a baculovirus
transfer vector capable of transfecting the SF9 cells. The genes were also cloned into the
BamHI and NdeI sites of pET19KT, an E.coli expression vector.

A

B

Fig. 4-2 Formation of the 9X (A) and 12X (B) aggregate repetitive regions. The
respective aggregate monomer is in red. The figure shows destruction of the AgeI and
BspEI sites during ligation. Red arrows indicate the gel electrophoresis bands that
represent the specified sequences. Segments excited and purified are circled in red.
Reprinted with permission from Kyle Berg.
Bac-to-bac transfection
For successful transfection SF9 cells need to be in log phase (1.5-2.5 X 106
cells/mL) with greater than 95% viability, this was verified on a Vi-cell counter
(Beckman CoulterVi-CELL Cell Counter). 2 mL Grace’s Insect Medium,
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Unsupplemented was added to each well (6-well plate). Cells were seeded at 8 X 105 per
well and allowed to adhere for 15 minutes at room temperature. For each transfection 8
µL Cellfectin II (Thermo Fisher Scientific 10362100) was added to 100 µL Grace’s
Medium, 1 µL baculovirus DNA was added to 100 µL Grace’s Medium and the two
mixtures were combined. The DNA-lipid mixture was added dropwise onto the cells and
they were incubated for 3-5 hours at 27°C. The transfection mixture was removed and
replaced with 2 mL SF-900 II media (SF-900 IITM SFM Thermo Fisher
Scientific10902096). The transfected cells were allowed to grow for 3 days at 27°C.
After 3 days the media was collected from each well and centrifuged at 500 X g for 5
minutes to remove cells and large debris. The clarified supernatant was transferred to a
15 mL conical, this is the P1viral stock.
To amplify the viral stock to a higher titer, cells were plated at 2 X 106 cells/well
(6 well plate) and incubated at room temperature for 1 hour. After an hour 0.5-1 MOI
(multiplicity of infection) P1 stock was added to the wells. The cells were incubated at
27°C for 2 days, then the media was removed and centrifuged at 500 X g for 5 minutes to
remove cells and large debris, this is the P2 viral stock.
Culturing and Expression: SF9 cells
In order to express the aggregate proteins, 6 X 105 cells/well were plated in a 24
well-plate and allowed to attach for 30 minutes. The media was removed and the cells
were washed with fresh media. 300 µL fresh media was placed on the cells and
baculoviral stock was added at the desired MOI. The cells were incubated at 27°C for up
to four days. When conducting assays MOIs of 1, 2, 5, 10 and 20 were tested, as well as
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culturing times of 1 day, 2 days, 3 days and 4 days. When the expression cultures were
ready to be harvested the cells were resuspended in the media and transferred to 15 mL
tubes. Cultures were centrifuged at 1000 rpms for 5 minutes and the supernatant and cells
were separated. The SF9 cells were resuspended in a 1:3 (g:v) binding buffer (8M Urea,
20 mM Tris-HCL, 0.5 M NaCl, 2 mM EDTA). Sonication was conducted for 30 seconds
at 1 W (QSonica ¾” diameter probe). The cell waste was separated from the cell lysate
by centrifugation at 14,000 rpms for 10 minutes.
Once expression assays confirmed the optimal MOI and time (days) to perform
culturing for aggregate expression, the process was scaled up to T25 and T75 flask
culture. These cultures were conducted using 7 mL and 12 mL SF900 II media,
respectively. Within the cells was determined to be where the protein was contained and
were sonicated accordingly.
Culturing and Expression: E.coli
Two-liter flask cultures were used to express aggregate proteins in E.coli. A 5 mL
LB media (Miller 71753-6) with kanamycin (100 mg/L) tube culture was grown for 8
hours at 37°C and 2500 rpms, and used to inoculate the two-liter flask culture containing
750 mLs LB media with kanamycin. Flask cultures were grown for 16 hours under the
optimal conditions listed above. The flash culture was grown until OD600 of 80 was
reached and then inoculated with 1 mM IPTG and grown for an additional 4 hours.
Bacteria was harvested via centrifugation at 6000 rpms for 30 minutes and the cell pellet
was processed in an 8M Urea binding buffer (8M Urea, 20 mM Tris-HCL, 0.5 M NaCl, 2
mM EDTA) at 1:3. Sonication was conducted at 1 W for 4 minutes, a minute rest, and
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repeated 3 times (QSonica ¾” diameter probe). The cell lysate was harvested through
centrifugation at 6000 rpms for 30 minutes, retaining the supernatant as the final cell
lysate.
Purification
Some issues arose with purification when the cultures were scaled up to the T25
and T75 flasks. All the small scale, Eppendorf sized, purifications yielded recombinant
aggregate proteins that were visible when analyzed via western blot or dot blot, but any
larger expressions that were processed in plastic conicals showed no protein on the
western blots. It was determined that the aggregate proteins were sticking to the conical
tubes used for purification, this is most likely due to either the highly hydrophobic nature
of spider silk proteins or the post-translational glycosylation of the aggregates, or a
combination of both characteristics. In order to remove the proteins a wash with 200 µL 5
mM NaOH and then the solution was placed in Eppendorf tubes that the protein did not
stick to, and neutralized with 200 µL 5 mM Tris. These samples were lyophilized and the
resulting protein powder was suspended in 500 µL water. Another option to interrupt any
interactions between the protein and the container is to use a siliconizing agent readily
available from companies such as Thermo Fisher Scientific to pre-treat the conicals or
other containers used when processing the SF9s containing aggregate silk protein.
Western Blot Analyses and Coomassie
Western Blots were conducted on all processed cell pellets from the expression
assays and cell cultures to determine aggregate production in the culture. A 15 µL aliquot
was taken from each sample and a 1:1 volume 2XSABU (125 mM Tris-HCL, 8M Urea, 6
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mM EDTA, 10% SDS, 10% glycerin, 0.4% Bromophenol) was added to the sample.
Samples were boiled for 10 minutes and then loaded onto a 4-20% tris-glycine SDSPAGE gel (Invitrogen XP04200BOX) and run at 135 V for 90 minutes. Gels were
transferred to nitrocellulose membranes overnight at 25 mA in a wet transfer apparatus.
The blots were conducted on the nitrocellulose membranes with a primary antibody
produced in mice that targets the histidine tag (Rockland 200-303-382, 1:1000 dilution).
Some blots were conducted using a rabbit anti-mouse antibody conjugated with Alkaline
Phosphatase (AP) was used at a 1:5000 dilution (Abcam ab6729) and other blots were
conducted using a custom-built C-term antibody made in rabbits conjugated with
Alkaline Phosphatase (1:5000). The membranes were developed using 1-StepTM
NBT/BCIP Substrate Solution (Thermo Fisher Scientific 34042) for imaging.
Coomassie staining was also conducted on the samples with the same loading
onto a 4-20% gradient tris-glycine gel. The SDS-PAGE gels were run at 135 V for 90
minutes. Overnight stains were conducted with Coomassie Blue stain (Bio-rad 161-0786)
and were destained (40% methanol, 10% acetic acid, 50% water) for two hours with two
washes and then the gels were imaged with Azure Biosystems c200 gel documentation
platform.
Deglycosylation
In order to determine if the synthetic aggregate proteins produced in the SF9 cells
contained glycosylation the molecular weights of the synthetic proteins were calculated
with no glycosylation, just N-glycosylation, just O-glycosylation and glycosylation at
both the N- and O- locations. To calculate the different molecular weight of the protein
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with and without glycosylation an online calculator was used that added the sugars to the
amino group of asparagines (N-linked), or added a monosaccharaide to the hydroxyl
group of serine and threonine (O-linked) and a combination of the two types of
glycosylation (Table 4-1).

Table 4-1 Table showing the expected relative size of aggregate spider silk proteins
when glycosylated versus when no glycosylation is present.
Protein
3X aggregate +
linker

6X aggregate +
linker

9X aggregate +
linker

12X aggregate +
linker

Nglycosylation

Oglycosylation

MW
(kDa)

√
√

√
√

79.5
79.9
105.7
106.1

√
√

√
√

123.4
123.8
168.3
168.8

√
√

√
√

167.3
167.8
230.9
231.4

√
√

√
√

211.3
211.7
293.6
294

Deglycosylation of aggregate proteins produced in SF9 cells was conducted using
Protein Deglycosylation Mix II (New England BioLabs P6044S). This deglycosylation
kit deglycosylates proteins at both N- and O- amino acids. 100µg of the glycoprotein,
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aggregate, was dissolved into 40 µL water and 5 µL 10X Deglycosylation Mix Buffer 1
was added, as well as, 5 µL Protein Deglycosylation Mix II, solution was gently mixed.
Samples were incubated at room temperature for 30 minutes, then transferred to 37°C for
16 hours before analysis via Western blot. The protocol listed here does not denature the
protein. To denature the protein an incubation at 75°C for 10 minutes, followed by a
cooling step are conducted after the solution is made and before the deglycosylation mix
is added. Both of these methods were used for this research.
Results and Discussion
Four synthetic aggregate genes were created for this research, 3X, 6X, 9X and
12X, the 3X aggregate is a three repeat of the monomer repetitive sequence and was
synthesized and used to create the other larger proteins as described above. Both the 3X
and 12X aggregate genes were successfully cloned into the baculoviral transfer vector
pOET2. Work is being continued to insert the 6X and 9X aggregate into the vector,
which to date for reasons that have yet to be determined have not been successfully
cloned under any attempted ligation and transformation protocol parameters. Using the
bac-to-bac transfection techniques SF9 cells were transfected with the 3X and 12X
aggregate sequences. Expression studies were conducted using multiple MOIs
(multiplicity of infection), over the course of several days and by harvesting and
processing both the supernatant and the cells from the expressions to determine what the
best parameters for aggregate protein production were.
Expression assays conducted on 3X aggregate showed increasing crystallization
within the SF9 cells over a 4-day period, seen as an increase in cell size and change in
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morphology, (Figure 4-3), demonstrating successful production of the viral capsid
protein. After the expression assays were finished the supernatants and cell lysates were
analyzed on Coomassie’s to determine when protein was being expressed and if the
aggregate protein was being secreted into the media or being retained in the cell. It was
determined that the optimal MOIs for protein production were 5, 10 and 20. After 3 days
of expression all of the protein was still being accumulated in the cells and none was
secreted into the media until day 4, but even on day 4 there was still protein retained in
the cells (Figure 4-4). Based on these results it was concluded that the best parameters for
3X aggregate protein expression in SF9 cells was at a MOI of 5 for 3 days, using only the
cells from the cultures to purify the protein.
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A

B

C

D

E

F

Fig. 4-3 Microscopic images of SF9 cells transfected with 3X aggregate. A and B are
images taken 1 day after expression, C and D are images taken 2 days after expression
and E and F are 3 days after induced expression, when cells are harvested.
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Fig. 4-4 Coomassie blue analyses of 3X aggregate protein expression in SF9 cells.
A) processed cell pellets from MOIs 1 (wells 1 and 8), 2 (wells 2 and 9), 5 (wells 3 and
10), 10 (wells 4 and 11) and 20 (wells 5 and 12) taken 3 days after induced protein
expression. B) the media, or supernatant, taken after 3 days induced protein expression in
two SF9 cell cultures at MOIs 1 (wells 1 and 8), 2 (wells 2 and 9), 5 (wells 3 and 10), 10
(wells 4 and 11) and 20 (wells 5 and 12). A positive control from a bacterially expressed
his-tagged protein is in well 6 in each sample.
Expression assays were also conducted using varying MOIs of P2 viral titers of
12X aggregate. Much like is seen in E.coli, there was no production of this much larger
rSSp seen in either Coomassie, western blot analyses or dot blot analyses. 12X aggregate
protein is anywhere from 211-294 kDa and it is hypothesized that this specific
recombinant protein is too large for the small eukaryotic SF9 cells to produce, which is
why we see production of the 109 kDa 3X aggregate protein but not of this protein. As
mentioned above, this is a common problem in E.coli production due to the host
organisms incapability to make a protein not only that large, but also as repetitive as
rSSps tend to be. This theory will be further examined once the 6X and 9X aggregate
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genes are successfully cloned into the pOET2 baculovirus vector and expression of the
genes can be examined.
Western blot analyses
Once it was determined what the best parameters for aggregate spider silk
production, western blot analyses were conducted on the cell lysates to verify aggregate
production (Figure 4-5). If the aggregate protein was unglycosylated it would be a 79.5
kDa protein, but if glycosylation were present then the protein would express at 106 kDa.
All of the 3X aggregate produced was 106 kDa, demonstrating that the protein is
glycosylated.

1

2

3

4

5

Fig. 4-5 Western blot analyses of a 106 kDa aggregate protein expressed in SF9
cells. A positive control is shown in well 2 of a bacterially derived synthetic his-tagged
protein. The wells show the following: 3) 3X aggregate expressed in SF9 cells with a
viral MOI of 5, 4) 3X aggregate expressed in SF9 cells with a viral MOI of 10, and 5) 3X
aggregate expressed in SF9 cells with a viral MOI of 20.
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In order to further develop that the aggregate proteins being produced by the SF9
cells were glycosylated a deglycosylation kit was used on the cell lysates. The
deglycosylation was conducted on two different 3X aggregate protein expressions that
were previously verified as 106 kDa on a western blot analyses, two samples from each
was used to compare if deglycosylation was altered when the protein was denatured first
or under conditions that did not denature the protein. These deglycosylated samples were
examined via western blot analyses and showed that some deglycosylation took place in
all the samples and that denaturing the protein had little, if any, effect on the amount
deglycosylation achieved (Figure 4-6). All the samples showed the glycosylated protein
at 106 kDa and laddering down to what would be an unglycosylated 3X aggregate protein
at ~80 kDa. This incomplete deglycosylation could be due to several factors, including:
1) the concentration of the protein was too high to have 100% deglycosylation, 2) the
number of attached sugars to the N- and O-linked regions proved too many for the
enzyme to detach them all and 3) secondary structures inhibited the deglycosylation
reaction by hiding the glycosylated sites within the structure of the protein.
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Fig. 4-6 Western blot analyses of a 106 kDa aggregate protein expressed in SF9
cells and then treated with a deglycosylation kit. A positive control is shown in well 8
of a bacterially derived synthetic his-tagged protein. A negative control of water is in
well 7. The wells show the following: 3) 3X aggregate T75 #1 expressed in SF9 cells
treated with deglycosylation kit, 4) 3X aggregate T75 #1 expressed in SF9 cells
denatured and treated with the deglycoslation kit , 5) 3X aggregate T75 #3 expressed in
SF9 cells and treated with the deglycosylation kit and 6) ) 3X aggregate T75 #3
expressed in SF9 cells denatured and treated with the deglycoslation kit.

Future Research
Synthetic aggregate protein production research has only begun, and there are still
many interesting and scientifically significant experiments to be performed. While a
synthetic aggregate has been produced there are other larger constructs that have been
created, but as of yet unsuccessfully expressed in Spodoptera frugiperda (SF9 cells) or
any other host system. It will be interesting to obtain mechanical data on synthetically
derived aggregate, this would either prove or disprove the theory that a synthetic
aggregate would still be of use as a glue and whether the rSSps would behave similarly to
native aggregate. Of particular interest, is whether or not synthetic aggregate can be used
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in an aqueous environment like the native aggregate. If aggregate rSSps can be used as a
marine/aqueous glue, there will not only be a whole new avenue of research and product
development available for discovery, but a much higher demand commercially.
Another avenue for future research is the insertion of the synthetic aggregate
proteins into alternative hosts to see if the protein inherently has the same properties and
can be produced at a higher yield. As of right now 3X, 12X and 9X aggregate genes have
been inserted into pET19KT, an in-laboratory expression vector for E.coli. E.coli does
not post-translationally modify proteins to contain glycosylation. Aggregate proteins
created in E.coli should be an excellent comparison to aggregate proteins produced in
SF9 cells. Another interesting host is Medicago sativa, alfalfa, which naturally produces
glycosylated proteins and contains a much higher concentration protein and is capable of
producing higher yields synthetic protein. As the aggregate rSSp sequences have already
been cloned into an agrotransformation mediating vector, it would be an ideal host for
long term production.
Conclusion
This research has shown, for the first time, that a synthetic aggregate protein can
be produced in SF9 cells. The synthetic aggregate proteins were shown to be glycosylated
and were partially purified, and while a synthetic aggregate has been produced before
there is no evidence that anyone else has been able to produce a glycosylated synthetic
aggregate protein. While production via eukaryotic cell culture, specifically SF9 cells,
has been useful for preliminary research into synthetic aggregate production, other
production methods, such as alfalfa, need to be examined to create a commercially viable
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product. Also, research into material development and characterization has a long way to
go in order to delve into the full potential of aggregate as an industrial aqueous glue or
any other products. Now that glycosylated and non-glycosylated synthetic aggregates
have been produced and extracted, many new projects can be created and aggregate can
fully be examined.
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CHAPTER 5
ENGINEERING SIGNIFICANCE
The field of biological engineering has always aimed at creating
commercially viable engineered systems, designed using biology, applied sciences and
technology in innovative ways to produce tangible materials and processes. This
interdisciplinary field combines engineering principles, for designing, building and
testing products and processes, with research and development by utilizing biology,
medical and technology practices and knowledge. The research I conducted uses all of
these principles and methodologies to develop processes for production and purification
of recombinant spider silk proteins (rSSps) at a commercially viable level. Due to spider
silk’s remarkable strength and elasticity, as well as biocompatibility and biodegradability
characteristics, it is an ideal material for producing a plethora of diverse materials, more
specifically biomaterials for medical uses. One of the major limiting factors in rSSp
production is a bioengineered process capable of producing commercially viable
quantities of spider silk with mechanical characteristics similar to those found in the
native silks. The research projects presented in this dissertation all are aimed at
designing, building and testing both the processes to create rSSps and the resulting rSSps
themselves, ultimately aiming to create a superior and marketable rSSp production
system.
Spider silk production in E. coli was improved through molecular engineering and
bioprocessing. Molecular cloning was conducted by designing an expression vector that
included additional glycine and proline t-RNAs and a SHMT enzyme, increasing the
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glycine concentration within the cells. This redesigned vector was tested and
demonstrated an expression method capable of producing increased quantities rSSps.
Other research conducted in the spider silk laboratory since this particular research
project was completed in 2014, has improved rSSp bacterial production further through
modifying downstream processing and fermentation protocol redesign. Yields of greater
than or equal to 1 g/L rSSp are now common when using E.coli as the expression host.
This is a yield that was theorized to meet commercial demands using bacteria, although
efforts are currently being made to successfully upscale the process further, while
retaining high yields and maintaining costs.
Another system that was designed and engineered to create rSSps was Medicago
sativa, more commonly known as alfalfa. Research had been conducted in the past to
insert rSSps into plant hosts, but none of these processes ever resulted in native-sized
rSSps, in fact they were very small at ~25-40 kDa, or a purified product that could be
used to make marketable materials. The research presented in Chapter 3 shows the
expression of rSSps via a newly developed molecular engineered vector that was used to
transform alfalfa via Agrobacterium tumefaciens. This vector and agrotransformation
resulted in spider silk plants with rSSps ranging from 85-110 kDa. Not only was a new
expression system designed and built, but we were able to extract a crude product from
the alfalfa and create a new downstream process system using chlorophyllase and
precipitation to purify the rSSps. While work is ongoing to quantify the yield in the
transgenic plants, we now know that we can successfully create spider silk in plants and
that it is a viable production option for future work. This is the first demonstration of
plant-based spider silk production.
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Aggregate spider silk had never been synthetically produced prior to the research
presented in this dissertation. By designing a production process that yields synthetic
aggregate proteins that are post-translationally glycosylated, now materials can be
produced using the glue-like protein. Mechanical testing on aggregate materials are
theorized to show “stickiness” and remarkable adhesion properties, similar to those seen
in the native aggregate proteins. A novel characteristic of aggregate is the ability to work
as an adhesive even in the presence of water, allowing any products made with this
protein to be used in aquatic or marine conditions. There are no commercially available
marine glues that don’t rapidly breakdown, and a glue made with aggregate would
produce a tangible material for application in aquatic environments. Native aggregate
also is a naturally biodegradable material, which increases its’ appeal as a biological
marine glue. Utilizing Spodoptera frugiperdes as a host for aggregate spider silk
production has created a bioengineered process for creating a material with applications
in many technological fields. While there is still much work to be done to characterize the
synthetic aggregate proteins and some downstream processing necessary to increase
yields, this innovative research created synthetic aggregate that was glycosylated for the
first time through a bioengineered process.
In Biological Engineering, a driving theme is to use biology to design, test and
modify materials and processes. In my research I was able to design and modify three
different spider silk synthesis systems: 1) bacteria, 2) alfalfa, and 3) insect cells. Through
testing and further modification of the processes, I was able to determine that: 1) spider
silk production in E.coli could be improved upon the addition of glycine and alanine tRNAs, 2) spider silk could be successfully synthesized and purified utilizing alfalfa as a
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host, and 3) that the glue-like aggregate spider silk could be produced and posttranslationally modified with glycosylation in SF9 cells (Table 5-1). Using design, testing
and modification principles of biological engineering, synthetic spider silk production
was improved and new production systems were created through the research described
in this dissertation.
Table 5-1 Table showing the engineering significance achieved in this dissertation.
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CHAPTER 6
SUMMARY AND CONCLUSIONS
Historically, synthetic spider silk protein production is a low yielding process in
goats, E. coli, silkworms, plants, and all other biological organisms. There are two main
limiting factors in spider silk production: 1) low purification yields and 2) rSSps are not
capable of being produced at the same size as the native spider silks. Therefore, the
mechanical properties that synthetic proteins have are not as high as those seen in natural
spider silks. This research was able to address both of these issues through production in
three different hosts.
Spider silk yields in E.coli presented in Chapter 2 were increased by the
integration of glycine and proline t-RNAs and a SHMT enzyme in the expression vectors.
It was shown that by transferring the his-tag from the N-term to the C-term, no additional
protein was produced, although little to no protein truncation was seen. The work
conducted specifically for this dissertation created rSSp yields five times higher than
other vectors used. This research was combined with other projects conducted by several
post-doctorates in the spider silk laboratory, ultimately leading to a fermentation system
that could produce spider silk at a yield of up to 2 g/L, with a common yield of 1 g/L.
This is a yield that has been determined to meet commercialization demands if it can be
maintained when scaled up to larger fermentation volumes.
Spider silk genes were also inserted into alfalfa cultivars and a purification
process was developed utilizing a bacterial derived chlorophyllase molecule. This
research is the first evidence that rSSp can be produced in alfalfa leaves only and can be
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extracted. Yields have not been attainable in alfalfa due to the insolubility of the rSSp
under storage conditions, but alfalfa has been shown to be able to produce up to a 5%
yield synthetic protein and even a 2% yield spider silk would be enough to meet
commercial demands. The separation protocol designed for this research successfully
separates the rSSp from chlorophyll, which is a crucial step towards obtaining the first
pure rSSp from alfalfa.
For the first time a glycosylated synthetic spider aggregate silk was produced.
Due to aggregates glue-like characteristics and ability to be used in water, there are now
many different avenues for product development open to discovery. Now that aggregate
silk proteins have been synthetically produced in Spodoptera frugiperdes cells and a nonglycosylated version was produced in E.coli, research can be conducted to increase yields
and characterize the proteins.
Overall this research has increased rSSp yields in two different systems and
created a new synthetic spider silk in insect cells. Although further work is needed for all
of these projects, the work completed in this dissertation has been instrumental in
establishing and creating several synthetic production systems for rSSp production.
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